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Social consequences of 
harmful use of alcohol
The Health Research Board launched the latest publication in its Overview series 
on 25 November 2009.1 The purpose of Overview 9 was to compile and analyse 
the available data on the social consequences of harmful use of alcohol in Ireland 
and the methods used involved a combination of archival data, survey results and 
research literature.
The negative social consequences of alcohol include spouse/family 
problems, public disturbances, violence, and reduced work performance, 
which impact on all facets of society. Harmful use of alcohol has a 
negative effect on family well-being, and can contribute to relationship 
and marriage problems and impact on children, who are especially 
vulnerable to the effects of parental drinking. The effects of alcohol can undermine the fabric 
of family life and in many cases leave a legacy of neglect, abuse, chaos and damaged children. 
The emotional cost borne by these families is huge.
Garda data were analysed for the years 2003–2007 to examine the contribution of alcohol to 
crime in Ireland. Between 2003 and 2007 the total number of drunkenness, public order and 
assault offences increased by 30%, from 50,948 to 66,406. The typical profi le of a drunkenness, 
public order or assault offender was that of a young male aged under 24 years. Young people 
aged 18–24 were responsible for two-fi fths of offences. Those aged under 18 years accounted 
for 17% of offenders, and the total number of offences among minors increased from 6,531 in 
2003 to 10,037 in 2007, an increase of 54%.
Approximately half of all offences occurred at the weekend. Just under half of adult offences 
occurred between midnight and 4.00 am, with a peak at 2.00 am, which coincides with 
weekend closing time in many licensed premises, when large volumes of people spill onto 
the streets, often in a state of intoxication. Drunkenness and public order offences among 
minors tended to occur earlier at night than those among the adult population. The number 
of offences was highest for the week during which St Patrick’s Day occurs, the last week in 
October and the two weeks around Christmas and New Year’s Day.
The number of drink-driving offences increased by 74% between 2003 and 2007, from 11,421 
to 19,864. The largest increase (32%) was observed between 2005 and 2006, which can be 
explained by the introduction of legislation permitting random breath testing in 2006. 
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Social consequences of harmful use of alcohol (continued)
Males accounted for 90% of drink driving offenders. The largest proportions of both male and female 
offenders were in the 18–24-year age group, followed by the 25–29-year age group. Over half (52%) 
of all drink-driving offences were recorded between midnight and 4.00 am, and 54% were recorded 
on a Saturday or Sunday.
Data from four national drinking surveys (2002–2006) were analysed to examine social harm in the 
general population. The likelihood of experiencing at least one of the four social harm indicators 
(fi ghts, or harm to friendships, home life or work) in the previous year due to the drinker’s own 
alcohol use was one in fi ve (21%), with men twice as likely to report social harms compared to 
women (men 28%, women 13%). The overall prevalence of experiencing at least one of the social 
harms was signifi cantly higher among those who engaged in weekly risky single-occasion drinking 
(RSOD) (36%) in comparison with less frequent risky drinkers (16%) and with those who did not 
engage in risky drinking (5%). Younger participants were more likely to report that they experienced 
fi ghts and work problems, while harm to home life was more common among those aged 35 years 
and over.
Harm to others besides the drinker in the previous year was examined, using fi ve indicators: family 
problems, having been a passenger with drunk driver, been hit or assaulted, had fi nancial trouble or had 
property vandalised as a result of someone else’s drinking. The overall prevalence of experiencing at least 
one of these negative consequences from someone else’s drinking was over one in four (28%).
While men experienced more social harms from their own drinking than did women, both men 
and women experienced similar levels of harm from someone else’s drinking. More women than 
men reported the experience of family and money problems. Family problems were experienced 
equally by those who drank and those who did not drink. Men were more likely to experience 
the negative consequences of being a passenger with a drunk driver and of being assaulted. The 
risk of experiencing either of these harms increased as the frequency of risky drinking by the 
victim increased. The younger age groups, of both men and women, were more likely to report 
experiencing assaults and being a passenger with a drunk driver.
The harmful use of alcohol is a serious public health problem in Ireland, and is a major factor in 
social problems such as violence, family disharmony and child abuse and neglect. Alcohol-related 
harm is not restricted to the individual drinker, but has negative consequences for families, innocent 
bystanders and the wider community. The fi ndings of this Overview illustrate the urgent need for the 
introduction of a co-ordinated national alcohol strategy. 
(Deirdre Mongan)
Mongan D, Hope A and Nelson M (2009) 1. Social consequences of harmful use of alcohol in Ireland. 
HRB Overview Series 9. Dublin: Health Research Board.
‘Message in a Bottle’ seminar
‘Message in a Bottle’, an alcohol policy seminar, 
was hosted by Ballymun Local Drugs Task 
Force and Dublin North East Local Drugs Task 
Force in the Carlton Airport Hotel, Santry, on 
16 September. The purpose of the conference 
was to improve current knowledge and 
understanding of issues relating to alcohol at 
an individual, societal and environmental level. 
It was felt that, with a better understanding of 
policy and practice, local communities would be 
able to inform policy both locally and nationally.
Keynote speakers on the day were Mr Peter 
Sheridan and Dr Ann Hope. Mr Sheridan is 
an acclaimed fi lm and theatre director and he 
shared his personal experiences of alcohol. Dr 
Hope has extensive experience in national and 
international work in alcohol policy. 
In her presentation she discussed alcohol policy 
from an Irish perspective and outlined the policy 
interventions that are most effective in 
reducing alcohol-related harm. Seven guest 
speakers presented a diverse range of topics 
relating to alcohol policy, drinking culture, 
alcohol treatment and alternative alcohol-free 
social gatherings.
(Vivion McGuire)
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3The Health Research Board (HRB) published the fi rst national 
report on non-poisoning deaths among drug users in 
Ireland in November 2009.1 The data presented describe 
trends in non-poisoning deaths (deaths due to traumatic or 
medical causes) among drug users between 1998 and 2005. 
This paper is a companion to HRB Trends Series 4, which 
analysed trends in deaths by poisoning (directly drug-related 
deaths).2 The data used for the analysis were obtained from 
the National Drug-Related Deaths Index (NDRDI) maintained 
by the Alcohol and Drug Research Unit of the HRB. 
Overall, the annual number of drug-related deaths and 
deaths among drug users recorded in the NDRDI increased 
in the years 1998–2005 The total number of deaths in the 
eight-year period was 2,441, of which 885 (36.3%) were 
non-poisonings.
Of the non-poisoning deaths with a known cause (n=746), 
over half (476, 63.8%) were the result of trauma. Figure 1 
shows that the annual number of these deaths more than 
doubled over the reporting period. The annual number of 
deaths from medical causes increased by almost 500% over 
the same period. 
Half of the deaths due to trauma were of young men aged 
between 20 and 29 years. The most common causes of death 
due to trauma were hanging (174, 36.5%) and road traffi c 
collisions (95, 20.0%). Almost half of those involved in road 
traffi c collisions were driving a vehicle at the time of the accident.
Alcohol was present in nearly three-fi fths (241, 58.5%) of 
the deaths due to trauma that had a positive toxicology. 
Cannabis was the illicit drug most commonly found in the 
toxicology results of deaths due to trauma (227, 55.1%).
When the traumatic deaths that had a positive toxicology were 
analysed by type of death, cannabis (40, 67.8%), opiates (24, 
40.7%) and cocaine (18, 30.5%) were found in the greatest 
proportions in deaths due to violence (shooting, stabbing 
or assault). MDMA (ecstasy) (26, 28.6%) was found in the 
greatest proportion in deaths due to road traffi c collisions.
Over three-quarters of the deaths due to medical causes 
were of males, and the majority were aged between 30 
and 44 years. The most common medical causes of death 
were cardiac events (67, 24.8%), followed by respiratory 
infections (48, 17.8%) and liver disease (31, 11.5%). 
The majority (180, 66.7%) of drug users who died of 
medical causes had a history of opiate use. Three-fi fths (19, 
61.3%) of those who died of liver disease had a history of 
alcohol dependency. The highest numbers of cocaine users 
(n=12) and cannabis users (n=24) were among those who 
died from a cardiac event.
Of the total number of deaths (including poisoning and 
non-poisoning deaths) recorded by the NDRDI in the period 
1998–2005, 192 (7.9%) cases had a documented history of 
a blood-borne viral infection. The annual number of these 
cases increased from nine in 1998 to 41 in 2005.
The number of drug users who have acquired a blood-
borne viral infection highlights the need for continued and 
expanded harm reduction programmes, including treatment 
for problem alcohol use, to reduce the risk of infection and 
prevent the long-term health consequences of liver damage.
The number of drug users who died from hanging or from 
drowning supports the argument that substance misuse is 
related to suicide. There is a need for increased awareness 
and education around this issue, especially for those with 
a dual diagnosis of mental health and substance misuse 
problems who are already in treatment, and those who 
present at emergency rooms with non-fatal drug- or alcohol-
related injuries.
The number of drug users who were driving at the time of 
their death and had a positive toxicology is further evidence 
of the need for more reliable statistics on drink/drug driving. 
There is a need for expansion of the forensic analysis 
programme to ascertain the true incidence of driving while 
under the infl uence of drugs and/or alcohol. Unfortunately, 
there is currently no reliable system of road-side testing for 
the presence of drugs in the body.
The correlation of toxicology and drug-use history with the 
type of death recorded supports the argument that drug 
use is contributing to the premature death of drug users in 
Ireland. More effective measures are required to educate 
drug users about the health consequences of drug use, 
particularly the cardio-toxic effects of cocaine.
The continuing upward trend in drug-related deaths revealed 
in this paper and in its predecessor, Trends Series 4, refl ects 
the increasing numbers in the population who are consuming 
drugs and taking risks and who have acquired infections or 
developed medical conditions associated with drug use. 
(Ena Lynn, Suzi Lyons, Simone Walsh and Jean Long)
This report may be downloaded from the publications 
section of the HRB website at www.hrb.ie. 
Lynn E, Lyons S, Walsh S and Long J (2009) 1. Trends in 
deaths among drug users in Ireland from traumatic and 
medical causes, 1998 to 2005. HRB Trends Series 8. 
Dublin: HRB.
Lyons S, Lynn E, Walsh S and Long J (2008) 2. Trends in 
drug-related deaths and deaths among drug users in 
Ireland, 1998 to 2005. HRB Trends Series 4. Dublin: HRB.
Trends in drug-related deaths in Ireland
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Figure 1 Non-poisoning deaths among drug users, NDRDI 1998 to 2005 (N=746)
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4Table 1  Alcohol content of alcohol beverages
Beverage type Serving size description Serving size (ml) Alcohol content (ABV%) Grams of pure alcohol
Beer Half pint/glass 284 4.3 9.8
 Small can/long neck bottle 330 11.4
 Large can 500 17.2
 Pint 568 19.5
Cider Half pint/glass 284 4.5 10.2
 Small can/long neck bottle 330 11.9
 Large can 500 18
 Pint 568 20.4
Alcopops/RTD Long neck bottle 275 5 11
 Large bottle 700 28
Wine Small glass 100 12.5 10
 Quarter bottle 187.5 18.8
 Half bottle 375 37.5
 Bottle 750 75
Liqueur Glass 71 17 9.7
 Bottle 700 95.2
Sherry/port Glass 71 20 11.4
Vodka/rum/gin Single glass 35.5 37.5 10.7
 Double glass 71 21
 Half bottle 350 105
 Bottle 700 210
Whiskey/brandy Single glass 35.5 40 11.4
 Double glass 71 22.4
 Half bottle 350 112
 Bottle 700 224
Source: Hope (2009)
What constitutes a ‘standard drink’?
Alcohol has harmful properties; it is an intoxicant and a 
drug, and the risks associated with it are extensive. There 
is no clear level of drinking below which alcohol-related 
accidents, injuries or diseases do not occur. In other words 
there is no known ‘safe’ or ‘sensible’ level of alcohol 
consumption for any one individual. A recent report by the 
Health Service Executive examined the different alcoholic 
beverages currently available in Ireland in terms of beverage 
categories, the alcohol content, the serving size of typical 
drinks and other relevant information.1 
There is limited evidence of an impact of alcohol warning 
labels on drinking behaviour and alcohol-related harm. 
However, a European report on alcohol and labelling2 
concluded that consumer protection principles would 
suggest that where there are risks to health in consuming 
alcohol, particularly during pregnancy, when taking 
medication, or when driving or operating machinery, 
consumers should be informed about those risks.
In Ireland, there is much confusion about what constitutes 
a typical or ‘standard drink’. Part of the confusion stems 
from the use of the ‘UK unit’, which is inappropriate in the 
Irish context. The UK unit was devised in the early 1970s 
as a simple method to calculate the alcoholic strength in 
different drinks. The purpose was to help scientists and 
health professionals in the clinical setting estimate alcohol 
consumption for comparative purposes. The measure 
used was called a ‘unit of alcohol’ and related to the most 
common drinks and alcohol content of drinks served in 
the UK. A ‘UK unit of alcohol’ is found in a half pint of beer 
(3.5% ABV) or a small glass of wine (100 ml) or a single 
measure of spirits (1/6 gill) and equals 8 grams of pure 
alcohol. Although the UK unit was used in Ireland, it did 
not refl ect the typical strength or serving measure of drinks 
sold in Ireland, where a single measure of spirits is larger, 
at 1/4 gill. It is therefore not appropriate to use the UK unit 
measure when describing a standard drink in Ireland.
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5Road Trafﬁ c Bill provides for lower BAC limits
The Road Safety Strategy 2007–2012 published in October 
2007 recommended lowering the legal blood alcohol 
concentration (BAC) limit for drivers by June 2009. On 
30 October 2009, Transport Minister Noel Dempsey TD 
published the Road Traffi c Bill 2009, which provides for 
the introduction of reduced BAC limits for drivers and 
mandatory testing of drivers involved in collisions.1
The Bill provides for a reduction from the current legal limit 
of 80 mg of alcohol per 100 ml of blood to: 
20 mg per 100 ml for learner, novice and • 
professional drivers; and 
50 mg per 100 ml for other drivers. • 
The aim of this Bill is to improve road safety, save lives and 
reduce serious injuries on our roads. According to Minister 
Dempsey, ‘Intoxicated driving is one of the main causes of 
fatalities and injuries on our roads and that is not acceptable. 
The research in this area is conclusive and irrefutable. 
Reducing the BAC from its current limit of 80 mg has a 
proved benefi cial effect and will save lives and reduce serious 
injuries throughout Ireland.’
However, since publication of the Bill, it has been reported 
that the evidential breath-testing machines used in Garda 
stations to measure the alcohol in a driver’s breath cannot be 
recalibrated to the 20 mg limit proposed for inexperienced 
and professional drivers. The Medical Bureau of Road Safety 
estimates that it will be the middle of 2011 at the earliest 
before new replacement breath-testing machines can be 
purchased, tested and installed in Garda stations.2 Alcohol is 
a major factor in roads deaths in Ireland and in 2003 alcohol 
was a contributory factor in 110 (36.5%) of 335 fatalities.3 
Lower BAC limits consistently produce positive results in 
relation to alcohol-related road traffi c collision rates. For a 
driver with a BAC of 50 mg the risk of crashing a vehicle is 
double that for a person with a zero BAC and at the current 
Irish BAC limit of 80 mg the risk is 10 times greater.4 Given 
the clear evidence that lower BAC limits improve road safety, 
it is very disappointing that we have to wait another 18 
months at least for the important legislation proposed in this 
Bill to be enacted. 
(Deirdre Mongan)
Department of Transport (2009) Minister Dempsey 1. 
publishes Road Traffi c Bill 2009. Press release dated 
30 October 2009. www.transport.ie/pressRelease.
aspx?Id=144
Labanyi D (2009, 6 November) Drink-drive changes to 2. 
be delayed until 2011. Irish Times. www.irishtimes.com/
newspaper ireland/2009/1106/1224258194074.html 
Bedford D, McKeown N, Vellinga A and Howell F (2006) 3. 
Alcohol in fatal road crashes in Ireland in 2003. Naas: 
Population Health Directorate, Health Service Executive.
Babor T, Caetano R, Casswell S, Edwards G, Giesbrecht 4. 
N, Graham K et al. (2003) Alcohol: no ordinary 
commodity. Research and public policy. New York: Oxford 
University Press.
A pilot study undertaken in 2000 showed that a typical drink 
in Ireland was equal to 10 grams of alcohol and called a 
‘standard drink’.3 In the international arena, a standard drink 
is the usual term used. The UK unit (8 grams) is the lowest 
standard drink measure used. Some countries, including 
Spain, Italy, New Zealand and Australia, use 10 grams as 
their standard drink measure.
To establish the standard drink in Ireland, the fi rst step 
was to calculate the amount of pure alcohol in each of the 
alcoholic beverages. This involved multiplying the serving 
size of the drink (millilitres) by the alcohol content (% ABV) 
of the drink and dividing by 1.25 (1 ml=1.25 g) to establish 
the grams of pure alcohol in that specifi c drink (Table 1).
Two of the most popular serving sizes, a pint of beer and 
a quarter bottle of wine, are often mistakenly regarded 
as a standard drink where in fact they are equivalent to 
two standard drinks each. As a general guide for low-risk 
drinking, the recommended upper weekly limit used in 
Ireland is based on the UK unit – 14 units for women and 
21 units for men. However, when those low risk drinking 
guidelines are translated into Irish standard drinks (10 
grams), the Irish low risk weekly guidelines should be 11 
standard drinks for women and 17 standard drinks for 
men. To provide a general estimate of the average number 
of standard drinks consumed in Ireland, the per capita 
fi gures for 2006 were utilised. This suggests that on average 
approximately 21 standard drinks are consumed each week 
by every adult aged 15 years and over. This is a conservative 
fi gure given that abstainers are not excluded and represent 
about 20% of the adult population. Over a year this level of 
drinking is equivalent to 548 pints or 143 bottles of wine or 
51 bottles of vodka per adult.
It is hoped that the fi ndings of this study will help clinicians 
and health professionals to more accurately assess patient 
alcohol intake, provide a valid measure for inclusion in 
alcohol screening tools and help to inform policy on product 
labelling and provision of other relevant health information.
(Ann Hope and Deirdre Mongan)
Hope A (2009) 1. A standard drink in Ireland: what strength? 
Dublin: Health Service Executive.
Deutsche Hauptstelle Fur Suchtfragen e.V. (DHS) (2008) 2. 
Consumer labelling and alcoholic drinks. Hamm: DHS 
(German Centre for Addiction Issues).
Hope A (2000) 3. Typical drinks in Ireland. Dublin: 
Department of Health and Children.
What constitutes a ‘standard drink’? (continued) 
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62009 report on the drugs situation 
in Europe 
The annual report of the European Monitoring Centre for 
Drugs and Drug Addiction (EMCDDA) on the drugs situation 
in Europe was published on 6 November.1 While the report 
points to a stable situation in relation to heroin, and confi rms 
reports of a stabilising or even declining trend in the use of 
amphetamines and ecstasy, cocaine use continues to rise, 
albeit in a small number of countries. There are between 1.3 
and 1.7 million problem opioid users in the EU and Norway, 
with heroin responsible for Europe’s largest drug-related 
health and social costs. Some 12 million Europeans have 
tried cocaine in their lifetime, compared with around 11 
million for amphetamines and 9.5 million for ecstasy.
In Ireland, between 13,405 and 15,819 individuals used 
opiates in 2001; this estimate represents 1% of the opiate 
users in Europe. The picture in relation to cocaine is 
consistent with the broader European situation and the 
proportion of adults who reported having used the drug 
increased from 3% in 2002/3 to 5% in 2006/7. There 
was a slight increase in lifetime use of ecstasy, and use of 
amphetamines remained stable. 
Opiate situation in Ireland
Ireland, like over half of the countries in the EU, reported 
an increase in new opiate cases entering treatment since 
2005. After a decrease between 2001 and 2004, the number 
of such cases increased steadily between 2005 and 2007, 
when 9,769 cases received substitution treatment for opiate 
use. Problem opiate (mostly heroin) use accounted for 63% 
of those entering treatment for drug problems in Ireland, 
compared to the European average of 47%. 
In 2005, 159 drug-induced deaths occurred in Ireland and 
88% of fatal overdoses were associated with opiate use. The 
number of such deaths increased in Ireland in 2004 and 
2005, as they did in most European countries. Research in 
Ireland, Spain, the UK and elsewhere shows that the risk 
of overdose decreases substantially when heroin users are 
in substitution treatment. While there has been a dramatic 
expansion of methadone treatment services in Europe, and 
the treated population has grown steadily, the number of 
methadone-related deaths has fallen. 
With regard to infectious diseases, the Health Protection 
Surveillance Centre reported that there were 1,381 
diagnosed HIV cases in Ireland at the end of 2007, probably 
infected through injecting drug use. Data from blood-borne 
viral prevalence studies completed between 1995 and 2001 
indicated that around 10% of injecting drug users attending 
drug treatment tested positive for antibodies to HIV and 
70% for antibodies to hepatitis C; this places Ireland among 
the low-prevalence countries for HIV and among the high-
prevalence countries for hepatitis C. 
The number of heroin seizures in Ireland increased from 612 
in 2004 to 763 in 2005, and, more sharply, to 1,254 in 2006 
and to 1,698 in 2007; the latter increase is higher than the 
10% increase between 2006 and 2007 in heroin seizures 
reported in some European countries. 
Cocaine situation in Ireland
The proportion of adults in Ireland who reported using 
cocaine (including crack) at some point in their lives 
increased from 3% in 2002/3 to 5% in 2006/7; the fi gures 
for young adults also showed an increase, from 5% in 
2002/3 to 8% in 2006/7. The proportion of young adults 
who reported using cocaine in the last year increased from 
2% in 2002/3 to 3% in 2006/7; the range for current 
cocaine use among young adults in Europe was between 
0.2% and 5.4% placing Ireland among the high-prevalence 
countries (such as the UK, Spain and Italy). 
Like Ireland, many countries across Europe reported an 
increased demand for treatment for problem cocaine use. 
The number of treated cases in Ireland who reported cocaine 
as a main problem drug increased considerably, from 81 in 
2001 to 770 in 2007; in 2007, 462 cases entered treatment 
for the fi rst time. In 2007, cocaine use (mostly powder) 
accounted for 13% of those who entered treatment for 
drug problems in Ireland, compared to an average of 16% 
across Europe. The number of cocaine seizures in Ireland has 
increased with time, from 515 in 2003 to 1,749 in 2007. 
Amphetamines, ecstasy 
Amphetamine use is relatively uncommon in this country 
and Ireland is among the low-prevalence countries in 
Europe. Ecstasy use is more common than amphetamine use 
among young adults in Ireland. The proportion of young 
adults who reported using ecstasy in the last year remained 
relatively stable at 2.3% in 2002/3 and 2.4% in 2006/7, 
which places Ireland among the medium-prevalence 
countries. The number of treated cases who reported ecstasy 
as a main problem drug decreased considerably, from 219 in 
2001 to 129 in 2007. 
Cannabis 
Cannabis was the most commonly used illegal drug in 
Ireland and its use has not declined as it has in other parts 
of Europe. The proportion of adults who reported using 
cannabis at some point in their life increased from 17% in 
2002/3 to 22% in 2006/7 and the proportion who used 
it in the last year increased from 5% in 2002/3 to 6.3% in 
2006/7, placing Ireland just below the EU average (7%). 
However, the number of treated cases reporting cannabis as 
a main problem drug decreased steadily. In 2007, cannabis 
use accounted for 16% of those entering treatment for drug 
problems in Ireland, compared to an average of 21% across 
Europe. Cannabis seizures account for the majority of all 
drug seizures in Ireland. 
(Brian Galvin)
EMCDDA (2009) 1. Annual report 2009: the state of the 
drugs problem in Europe. Luxembourg: Offi ce for Offi cial 
Publications of the European Communities. 
www.emcdda.europa.eu/publications/annual-report/2009 
drugnet 
IRELAND
7Participation in international drugs 
policy arena will add value to Ireland’s 
drugs strategy
British–Irish Council summit discusses 
illicit drugs
On 13 November 2009 the British–Irish Council (BIC) held 
its 13th summit meeting. The Irish Government delegation 
was led by An Taoiseach Brian Cowen TD, and included 
Éamon Ó Cuív TD, Minister for Community, Rural and 
Gaeltacht Affairs. The Council noted that the Sectoral Group 
on the Misuse of Drugs held three meetings during 2009.
In March, Guernsey briefed the group on the 1. 
introduction of its new legislation to ban ‘Spice’ 
and other psychoactive substances. The aim of this 
legislation is to disrupt the commercial importation 
and sale of such substances (as opposed to 
criminalising users). The issue of ‘Spice’ and 
‘legal highs’ has now come to prominence at EU 
level. Given the ongoing developments, the BIC 
Sectoral Group is in agreement that the issue should 
remain as a standing agenda item for discussion in 
future meetings.
In May, Dr Suzi Lyons of the Alcohol and Drug Research 2. 
Unit of the Health Research Board gave a presentation 
to the group on the development and the content of 
the country’s National Drug-Related Deaths Index, which 
was launched in late 2008. The Index gives Ireland an 
accurate picture of the levels of drug-related deaths, 
thus facilitating policy development in the drugs area.
A meeting held in September focused on prevention and 3. 
how Scotland was raising awareness among the overall 
population of the dangers of drug use through their 
national Know the Score campaign. 
The next ministerial meeting will be held in 2010 and ministers 
will discuss substance misuse in the prison setting and the 
responses necessary to address this issue, along with how best 
to provide effective treatment and rehabilitation options to 
this cohort. For further information visit 
www.british-irishcouncil.org
The new National Drugs Strategy for 2009–2016 (NDS) 
includes a blueprint for enhancing Ireland’s role in the 
international drugs policy arena.1 The Steering Group that 
drafted the NDS states: ‘Properly co-ordinated international 
co-operation can, and will, add value to the new NDS’. 
For the fi rst time Ireland’s responses to developments in 
international drugs policy will be centrally co-ordinated, 
by the newly established Offi ce of the Minister for Drugs 
(OMD). The Steering Group observes, ‘Given that virtually 
all the relevant government departments will be represented 
in the new Offi ce, such co-ordination should be easier to 
achieve and should become an on-going feature of their 
work’. Specifi c co-ordinating tasks will include:
circulation of draft speeches and briefi ngs to • 
be presented internationally among relevant 
government departments for prior observations and 
comment;
quarterly meetings of key offi cials from the relevant • 
government departments, or as the need arises; 
annual meeting chaired by the Minister for Drugs • 
to plan Ireland’s broad approach across the various 
issues and fora; and 
regular six-monthly updates at the Offi cial Forum for • 
Drugs (OFD), or as the need arises. 
The value to be gained from more effective co-ordination, 
according to the Steering Group, will derive partly from 
enhancing the effectiveness of efforts to address the drugs 
problem at international level and thereby increasing public 
safety, and partly from providing opportunities to share 
experiences with, and learn from, other countries. Minister 
for Drugs John Curran TD described the value to be gained 
from participating in EU and international drug policy fora as 
being ‘the ability to monitor trends, tackle supply reduction 
and learn from the successes and failures of drugs policies 
implemented by other countries’.2
Table 6.5 of the new NDS lists eight ‘key EU and other 
groups and committees’ on which Ireland is represented and 
the government departments and agencies which attend 
these meetings. The roles of these bodies are outlined in 
Table 1 (overleaf). It is through work on these groups and 
committees that the anticipated additional value may be 
expected to be delivered. The work of these bodies will, 
in turn, be driven by the goals and objectives agreed at 
international and national level, which are listed in 
Table 2 (overleaf). 
(Brigid Pike)
Department of Community, Rural and Gaeltacht Affairs 1. 
(2009) National Drugs Strategy (interim) 2009–2016. 
Dublin: Department of Community, Rural and Gaeltacht 
Affairs. paras 6.92–6.100. 
Curran J (2009) ‘Yes to Lisbon no to drugs’. Open 2. 
letter. Accessed 20 October 2009 at www.johncurrantd.
com/?id=95 
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Table 1 Key EU and other international drug policy groups and committees on which Ireland is represented 
Horizontal Working Party 
on Drugs (HDG)
The HDG is the European Council’s working party tasked with leading and managing the 
Council’s work on drugs. Meeting monthly, the HDG’s work covers all policy areas, and 
relevant working parties (including the Police Cooperation Working Party, the Customs 
Cooperation Working Party, the Multidisciplinary Group on Organised Crime, the Working 
Party on Public Health, and External Relations Working Parties) report to the HDG on their 
drug-related work. The task of leading and managing the work on drugs is performed both 
by the HDG itself and through drug troikas with third countries. The work programme is 
based on the EU Drugs Action Plan, which in turn is based on the EU Drugs Strategy. 
Commission on Narcotic 
Drugs (CND)
The CND is the central policy-making body of the United Nations in drug-related matters. 
Meeting once a year, the CND enables member states to analyse the world drug situation, 
and develops proposals to strengthen the international drug control system to combat the 
world drug problem. 
www.unodc.org/unodc/en/commissions/CND/index.html 
European Monitoring 
Centre for Drugs 
and Drug Addiction 
(EMCDDA)
The EMCDDA provides the EU and its member states with a factual overview of European 
drug problems and a common information framework to support the drugs debate. To 
realise its purpose, the EMCDDA coordinates and relies on a network of some 30 national 
monitoring centres (Reitox network) to gather and analyse country data according to 
common data-collection standards and tools. In Ireland, the Health Research Board is 
currently the national monitoring centre. The results of this national monitoring process 
are fed to the EMCDDA in Lisbon for analysis and are ultimately released in the EMCDDA’s 
annual report on the state of the drugs problem in Europe. 
www.emcdda.europa.eu 
Pompidou Group
The Co-operation Group to Combat Drug Abuse and Illicit Traffi cking in Drugs (Pompidou 
Group) is incorporated in the institutional framework of the Council of Europe and comprises 
35 member states, including Ireland. It provides a multidisciplinary forum where policy-
makers, professionals and researchers can discuss and exchange information and ideas on 
the whole range of drug misuse and traffi cking problems. The Pompidou Group’s work 
programme is organised around six platforms – prevention, treatment, criminal justice, 
research, ethics and airports.
www.coe.int/T/dg3/pompidou/
EU National Drug 
Co-ordinators Network
Broad policy issues are considered twice yearly by the EU Drug Co-ordinators Network. 
To date, offi cials in the National Drugs Strategy Unit in the Department of Community, 
Rural and Gaeltacht Affairs have represented Ireland on this network.
British–Irish Inter-sectoral 
Group on Drugs
Ireland has lead responsibility for advancing work with regard to tackling the misuse of 
drugs among the nine jurisdictions represented on the British–Irish Council. Information and 
experience of best practice in relation to topics ranging across both supply and demand 
reduction are shared at the meetings of ministers and of offi cials. Professionals and academics 
in the relevant fi eld also attend the meetings. www.british-irishcouncil.org 
Civil Society Forum on 
Drugs
Established in 2007 by the European Commission, the Civil Society Forum on Drugs meets 
at least once a year and serves as a platform for informal exchanges of views and information 
between the European Commission and civil society organisations in the EU. Membership 
is for a period of two years and at present 26 organisations are members of the Forum. 
The overall objective of the Forum is to feed specifi c grass-roots experience into future 
Commission proposals, and also into the work of monitoring the EU action plan on drugs. 
http://ec.europa.eu/justice_home/fsj/drugs/forum/fsj_drugs_forum_en.htm 
Multidisciplinary Group 
on Organised Crime 
(MDG) 
The MDG is a working party of the European Council, originally set up in 1997 to support 
implementation of the EU’s action plan on organised crime. Meeting monthly, the purpose of 
the MDG is to draw up guidelines for co-ordinating the fi ght against organised crime. It also 
deals with various other questions concerning organised crime.
drugnet 
IRELAND
9Participation in international drugs policy arena (continued) 
Table 2 Key dates in formulation and implementation of international illicit drugs strategies and action plans, 
and Ireland’s NDS, 2009–2019 
Year United Nations European Union Ireland
2009
Political Declaration adopted at 52nd • 
Session of CND
10-year Plan of Action on International • 
Cooperation towards an Integrated and 
Balanced Strategy to Counter the World 
Drug Problem, adopted in conjunction 
with the new Political Declaration
EU Drugs Action Plan 2009–2012 • 
published (to support implementation of 
the 7-year EU Drugs Strategy 2005–2012)
National Drugs Strategy (interim) 2009–• 
2016 launched
2012
Target date to achieve:
1.  measurable reduction of the use of drugs, of 
dependence and of drug-related health and 
social risks; and
2.  measurable improvement in the 
effectiveness, effi ciency and knowledge 
base of law enforcement interventions and 
actions by the EU and its member states 
targeting production, traffi cking of drugs, 
the diversion of precursors, including the 
diversion of synthetic drug precursors 
imported into the EU, drug traffi cking 
and the fi nancing of terrorism, money 
laundering in relation to drug crime.
2013 New EU Drugs Strategy and Action Plan? Mid-Term Review of National Drugs Strategy?
2014
CND to conduct high-level review • 
of implementation of 2009 Political 
Declaration and Action Plan
Economic and Social Council to devote a • 
high-level segment to a theme related to 
the world drug problem
General Assembly to hold a special session • 
to address the world drug problem
2016
Target date to:
create a safer society through the reduction • 
of the supply and availability of drugs for 
illicit use;
minimise problem drug use throughout • 
society;
provide appropriate and timely substance • 
treatment and rehabilitation services 
(including harm reduction services) tailored 
to individual needs; and
ensure the availability of accurate, timely, • 
relevant and comparable data on the 
extent and nature of problem substance 
use in Ireland.
2017 New National Drugs Strategy?
2019
Target date to eliminate or reduce 
signifi cantly and measurably:
1. illicit cultivation of opium poppy, coca 
bush and cannabis plant;
2.  illicit demand for narcotic drugs and 
psychopathic substances, and drug-related 
health and social risks;
3.  illicit production, manufacture, marketing 
and distribution of, and traffi cking in, 
psychotropic substances and synthetic 
drugs;
4. diversion of and illicit traffi cking in 
precursors; and
5. money laundering related to illicit drugs.
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Bridging the research gap in the ﬁ eld 
of illicit drugs 
The European Commission hosted a conference titled 
‘Bridging the research gap in the fi eld of illicit drugs in the 
EU’ in Brussels on 24–25 September 2009. 
At the conference, Dr Gerhard Bühringer and Dr Michael 
Farrell presented a mapping of drug-related research in 
the EU, based on their work for a report recently published 
by the European Commission.1 They documented the 
existence of both projects and research publications on illicit 
drugs. The projects and publications were classifi ed into 
fi ve themes: understanding drug-use behaviour, demand 
reduction, supply reduction, policy analysis and meta-
evaluations. The mapping process identifi ed that half of the 
projects examined the epidemiology of drug use and 30% 
tested a prevention or treatment intervention. There were 
very few projects on drug supply. 
Ireland had 22 research projects between 2001 and 2006 
and 66 publications in the four years 2001/2 and 2005/6. 
The majority of these projects and publications covered the 
epidemiology of drug use. 
Mr Wolfgang Gotz, Director of the EMCDDA, mentioned 
two challenges to bridging the gap between research and 
policy: the dearth of longitudinal studies and the need to 
improve methods of dissemination. 
There were three parallel sessions: connecting research 
policy and drug policy, gaps in current knowledge, and 
funding mechanisms in different EU countries. These sessions 
were carried over to the following day. In addition, delegates 
from Australia, Canada and the US shared their experiences 
of illicit drug research in their countries and of getting the 
fi ndings into policy and practice. 
(Jean Long)
Bühringer G, Farrell M, Kraus L, Marsden J, Pfeiffer-1. 
Gerschel T, Piontek D et al. (2009) Comparative analysis 
of research into illicit drugs in the European Union. Brussels: 
European Commission, Directorate-General for Justice, 
Freedom and Security.
Putting research evidence into practice 
In 1998 the US Institute of Medicine published a landmark 
report on bridging the gap between practice and research 
in community-based drug and alcohol treatment.1 
Subsequently, EU Action Plans 2000–2004,2 2005–20083 and 
2009–20124 called on EU member states to promote and 
disseminate evidence-based practice interventions to reduce 
demand for drugs. The recently published National Drugs 
Strategy (interim) 2009–20165 notes that
a signifi cant body of knowledge on evidence-based 
best practice in relation to dealing with problem 
drug use has been built up. However, a key challenge 
is to disseminate best practice among service 
providers to ensure that it is applied. (S. 5.41).
This article presents the fi ndings from a recent systematic 
review that evaluated the effectiveness of opinion leaders in 
changing practitioners’ behaviour, and sought to determine 
how this strategy might be used to bridge the research-to-
practice gap in the alcohol and other drugs (AOD) fi eld.6 
This work formed part of a larger systematic review to 
evaluate the effectiveness of a range of implementation 
strategies. In their report on the larger review, the authors 
state that ‘the rationale behind the use of opinion leaders 
as an educational strategy is that new information will be 
integrated more effi ciently into practice if a respected peer 
trains a practitioner’.7
The authors defi ne an opinion leader as an educationally 
infl uential individual who is (i) a recognised expert in their 
fi eld; (ii) more likely than others to facilitate the fl ow of 
new information; and (iii) has well-developed interpersonal 
skills. Also known as change agents and knowledge brokers, 
opinion leaders interpret the meaning of technically 
or conceptually diffi cult information for standard users.
Methods
They authors undertook a systematic review of the literature 
covering the period from 1966–March 2005, using a wide 
range of electronic databases, relevant websites and hand-
searching of reference lists. Inclusion criteria limited the 
review to controlled studies that collected baseline data 
and had a study period of at least three months. Outcome 
measures included process outcomes to assess utilisation of 
the innovation, e.g. changes in health care professionals’ 
behaviour, and patient outcomes to assess the impact of 
the innovation on patients’ health status. The quality of 
the studies was assessed on three domains, strength and 
relevance of the evidence and size of the effect, and was 
rated as good, average or poor.
Results
Four papers met the inclusion criteria for this review – one 
good-quality systematic literature review comprising eight 
randomised controlled trials, and three good-quality primary 
studies. A qualitative synthesis of the data was undertaken, 
as, due to the heterogeneity of the studies, a meta-analysis 
was not possible as no common measure of effect was 
considered justifi ed. Since none of the included studies 
were conducted in the AOD context, evidence is based 
on results from studies of health care professionals, e.g. 
physicians, nurses and surgeons. The studies used opinion 
leaders primarily to improve adherence to guidelines for 
management of various chronic conditions, e.g. asthma, 
heart disease and arthritis, which, according to the 
authors, have important parallels in management of 
AOD-related problems. 
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Overall, opinion leaders in the 11 studies identifi ed showed 
variable effectiveness in changing professional practice. Levels 
of effectiveness varied from not signifi cant to small-to-modest 
in some process outcomes in the better-quality studies; 
process outcomes assessed changes in the behaviour of health 
professionals. Overall, patient outcomes were not signifi cantly 
improved by the use of opinion leaders. The authors 
conclude: ‘While it may make intuitive sense for the use of 
well-respected peers to disseminate innovations, current 
evidence is sparse and inconsistent and fails to support the 
use of opinion leaders as change agents. These equivocal 
results may refl ect the heterogeneity across studies.’ 
(Martin Keane)
Institute of Medicine (1998) 1. Bridging the gap between 
practice and research: forging partnerships with 
community-based drug and alcohol treatment. 
Washington DC: National Academy Press.
Council of the European Union (2000) 2. EU Action Plan on 
Drugs 2000–2004. Brussels: Council of the European Union.
Council of the European Union (2005) 3. EU Action Plan 
on Drugs 2005–2008. Brussels: Council of the 
European Union.
Council of the European Union (2009) 4. EU Action Plan 
on Drugs 2009–2012. Brussels: Council of the European 
Union.
Department of Community, Rural and Gaeltacht Affairs5.  
(2009) National Drugs Strategy (interim) 2009–2016. Dublin: 
Department of Community, Rural and Gaeltacht Affairs.
Bywood P, Lunnay B and Roche A (2009) Effectiveness 6. 
of opinion leaders for getting research into practice 
in the alcohol and other drugs fi eld: results from a 
systematic literature review. Drugs: education, 
prevention and policy, 16(3): 205–216.
Bywood P, Lunnay B and Roche A (2008) 7. Effective 
dissemination: a systematic review of implementation 
strategies for the AOD fi eld. Adelaide: National Centre for 
Education and Training on Addiction. p. 44.
Problem opiate use in Ireland
An opiate is a drug containing opium or any of its derivatives 
which acts as a sedative and narcotic. Examples include 
heroin, methadone, morphine, codeine, hydrocodone, 
oxycodone, fentanyl and tramadol. Heroin is synthesised 
from morphine, a naturally occurring substance extracted 
from the seed pod of the Asian opium poppy plant.1 Heroin 
is available in three forms – a white powder, a brown powder 
or a black sticky substance, known as ‘black tar heroin’.
Data sources
In a repeat of a similar prevalence study in 2001–2001,2 
Dr Alan Kelly and colleagues estimated the prevalence of 
problem opiate users in Ireland in 2006 using a three-source 
capture-recapture method.3 The three data sources used 
were the Central Treatment List (of clients on methadone), 
the Hospital In-Patient Enquiry scheme and the Garda PULSE 
data. This article highlights some of the study fi ndings and 
presents data from the National Drug Treatment Reporting 
System (NDTRS),4 the National Drug-Related Deaths Index 
(NDRDI)5 and the Central Statistics Offi ce (CSO).6 
Estimation of the numbers of adult problem opiate users
Data from the three sources indicated that there were 
11,807 opiate users aged 15–64 years known to services in 
Ireland in 2006, and an estimated 8,983 users not known 
to the services (hidden population) (Table 1). The national 
prevalence estimate of opiate users in 2006 was between 
18,136 and 23,576; the point estimate was 20,790 (Table 
2). This estimate is likely to be infl ated (see footnote).7 
Twenty-eight per cent (5,886) of the estimated number 
lived outside Dublin and 72% (14,904) lived in Dublin. The 
respective rates per 1,000 of the 15–64-year-old population 
in Dublin and in the rest of Ireland are 17.6 and 2.9. 
Table 1 Number of opiate users known, estimated number hidden, prevalence estimate and population rate in Ireland, 
in Dublin and in the rest of Ireland, 2006
Age group Known number Estimated hidden 
number
Estimated 
prevalence
Rate/1,000 
population
Ireland 15–64 11,807 8,983 20,790 7.2
Dublin 15–64 9,442 5,462 14,904 17.6
Rest of Ireland 15–64 2,365 3,521 5,886 2.9
Source: Kelly et al. (2009)
Table 2 Estimated prevalence of opiate use in Ireland, in Dublin, and in the rest of Ireland, 2001 and 2006
2001 2006
Estimate Lower 
bound
Upper 
bound
Rate/1000 
population
Estimate Lower 
bound
Upper 
bound
Rate/1000 
population
Ireland 14,681 13,405 15,819 5.6 20,790 18,136 23,576 7.2
Dublin 12,456 11,519 13,711 15.9 14,904 13,737 16,450 17.6
Rest of Ireland 2,225 1,934 2,625 1.2 5,886 4,399 7,126 2.9
Source: Kelly et al. (2003, 2009)
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The point estimate increased by 42%, from 14,681 in 2001 
to 20,790 in 2006. The point estimate for Dublin increased 
by 20%, while the point estimate for the rest of Ireland 
increased by 165% – albeit from a low estimate in 2001. 
The rate of opiate use per 1,000 of the 15–64-year-old 
population living outside Dublin increased from 1.2 in 2001 
to 2.9 in 2006. 
Table 3 shows the 2006 estimate by age, gender and 
place of residence. Seventy-one per cent were male. One 
in fi ve (21%) was between 15 and 24 years old and half 
(51%) were between 25 and 34 years old. In Dublin, the 
rate of opiate use per 1,000 of the 15–24-year-old female 
population decreased by 62%, from 18.7 in 2001 to 7.2 in 
2006, which indicates that the number of younger women 
commencing opiate use has decreased. A smaller but still 
notable decrease in the rate of opiate use in Dublin was seen 
among males aged 15–24 years. 
Table 3 Prevalence estimate by age, gender and place 
of residence, 2006
Gender Age 
group
Ireland Dublin Rest of 
Ireland
All 15–64 20,790 14,904 5,886
Males 15–64 14,787 10,395 4,392
15–24 3,150 1,892 1,258
25–34 7,238 5,172 2,066
35–64 4,399 3,331 1,068
Females 15–64 6,003 4,509 1,494
15–24 1,159 701 458
25–34 3,298 2,605 693
35–64 1,546 1,203 343
Source: Kelly et al. (2009)
In an unpublished study, Kelly and colleagues report that 
retaining opiate users in treatment reduces their likelihood 
of being in contact with the gardaí (Dr A Kelly, personal 
communication, 2009). For example, only 12% of males 
aged 25–34 years who were known to the gardaí in 2001 
and were attending treatment services between 2001 and 
2006 were reported to be committing crime in 2006. This is 
in line with fi ndings from the ROSIE study8 and indicates that 
methadone treatment reduces the incidence of crime.
NDTRS data – treated opiate users
In 2007, 11,538 cases were treated for problem opiate use.4 
This is a 31% increase (2,734 cases) since 2002 and an 
increase of just over 7% (783 cases) since 2006 (Table 4). 
Two-thirds (7,643) of problem opiate users were • 
continuing in care, that is, they were already in 
methadone treatment on 31 December 2006 and 
continued to receive that treatment after 1 
January 2007. 
Just over one-fi fth (2,598) had received treatment • 
before and re-entered treatment in 2007. This 
refl ects the fact that problem opiate use is a recurring 
problem and requires repeated treatment over time.
Ten per cent (1,151) were new cases presenting for • 
treatment for the fi rst time. 
A small number of cases (146, 1.3%) were not clearly • 
identifi ed as either new or return cases. 
Of the 3,575 previously treated and new cases who entered 
treatment in 2007 and who reported opiates as their main 
problem substance, more than half used it daily, 10% used 
it on two to six days per week and 6% used it once a week 
or less. One-quarter had not used it in the month prior to 
treatment; this refl ects the transfer of stable clients to other 
types of treatment centres, such as general practice and 
medication-free residential services.
Between 2002 and 2007, 5,304 cases entered treatment for 
the fi rst time. The rate of new cases aged 15–64 increased 
from 28 per 100,000 in 2002 to 35 in 2007. The overall 
number of opiate cases was high in Dublin; however, the 
number of new cases was lower in 2007 than in 2002. Over 
the same period there was a signifi cant increase in new 
cases elsewhere in the country, with a steady increase in 
the midland, south eastern and north eastern counties. The 
number of new cases is an indirect indicator of recent trends 
in problem substance use.
There was a 54% (2,680) increase in the number of 
methadone treatment places between 2001 and 2007. 
This refl ects one of the benefi ts of the proactive approach 
of the National Drugs Strategy. It is important to note that 
methadone substitution is a long-term treatment that can 
take a number of years to show results. 
Of the 3,575 cases who entered treatment and reported 
opiates as their main problem substance in 2007, 52% 
smoked it, 40% injected it and 5% consumed it orally. 
From 2003 to 2007, decreasing proportions of cases 
reported injecting as their primary route of administration, 
while correspondingly increasing proportions reported 
smoking as their primary route.
The proportion of cases treated for opiates as a main 
problem substance who reported use of more than one 
substance decreased from 69% in 2002 to 63% in 2007. 
The decrease in polydrug use was observed among both 
Table 4 Opiate cases in treatment, by treatment status (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Number (%)
All cases 8804 9113 9542 10217 10755 11538
Continuous care cases 5601 (63.3) 5944 (65.2) 6433 (67.4) 6924 (67.8) 7269 (67.6) 7643 (66.2)
Cases entering treatment 3203 (36.4) 3169 (34.8) 3109 (32.6) 3293 (32.2) 3486 (32.4) 3895 (33.8) 
Of which:
Previously treated cases 2252 (25.6) 2280 (25.0) 2265 (23.7) 2395 (23.4) 2352 (21.9) 2598 (22.5)
New cases 809 (9.2) 808 (8.9) 737 (7.7) 803 (7.9) 996 (9.3) 1151 (10.0)
Treatment status 
unknown* 142 (1.6) 81 (0.9) 107 (1.1) 95 (0.9) 138 (1.3) 146 (1.3)
*Relevant data not recorded on the NDTRS form returned.
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new and previously treated opiate cases, but was more 
marked among the new cases. The reason for the decrease 
is not clear; it may be the result of an increase in the number 
of newer opiate users who have yet to develop chronic 
polydrug-using practices, or of improved history-taking 
practices by service providers. Polydrug use is one of the 
factors that can impede successful treatment for problem 
opiate use. Specifi c interventions, such as detoxifi cation from 
other drugs and contingency management, are required to 
address this problem.
Table 5 shows the additional problem substances used by 
cases entering treatment who reported opiates as their main 
problem substance. Between 2002 and 2007, cannabis, 
benzodiazepine and cocaine were the most common 
additional problem substances reported. Cannabis was top 
of this list in each of the six years. Benzodiazepine was the 
second most common additional substance between 2002 
and 2005, but was replaced by cocaine in 2006 and 2007. 
The number reporting cocaine as an additional problem 
substance increased by 59% over the period. The number 
reporting alcohol as an additional problem substance 
increased by 250% over the period. 
NDRDI data – deaths among opiate users
The NDRDI reported that there were 1,553 deaths as a result 
of poisoning between 1998 and 2005.5 In over half (839, 
54.0%) of these deaths, heroin, methadone or other opiates 
were implicated (either alone or in conjunction with other 
substances) (Table 6). Over one-third (292, 34.8%) of the 
opiate-related deaths were attributable to a single opiate. 
Of all the poisoning cases involving an opiate, 634 (75.6%) 
were male and 657 (78.3%) were aged between 20 and 44 
years; of those for whom employment status was known, 
445 (62.4%) were unemployed. 
Table 5 Additional problem substances used by cases entering treatment* who reported opiates as a main 
problem substance (NDTRS 2002–2007)
2002 2003 2004 2005 2006 2007
Additional problem 
substances used†
Number (%)
All cases 2114 2138 1932 2120 2261 2239
Cannabis 1075 (50.9) 1115 (52.2) 934 (48.3) 1060 (50.0) 1194 (52.8) 1106 (49.4)
Benzodiazepine 1005 (47.5) 909 (42.5) 785 (40.6) 875 (41.3) 936 (41.4) 788 (35.2)
Cocaine 609 (28.8) 782 (36.6) 752 (38.9) 811 (38.3) 966 (42.7) 969 (43.3)
Opiates‡ 598 (28.3) 559 (26.1) 550 (28.5) 560 (26.4) 572 (25.3) 443 (19.8)
Alcohol 153 (7.2) 246 (11.5) 245 (12.7) 332 (15.7) 457 (20.2) 536 (23.9)
Ecstasy 255 (12.1) 225 (10.5) 152 (7.9) 169 (8.0) 134 (5.9) 140 (6.3)
Amphetamines 59 (2.8) 47 (2.2) 31 (1.6) 23 (1.1) 40 (1.8) 45 (2.0)
Volatile inhalants 10 (0.5) 6 (0.3) 7 (0.4) 6 (0.3) 4 (0.2) 6 (0.3)
Other substance 57 (2.7) 48 (2.2) 49 (2.5) 45 (2.1) 37 (1.6) 50 (2.2)
*Excludes cases not normally resident in Ireland.
†By cases reporting use of one, two or three additional substances.
‡ Cases may report one type of opiate as their main problem substance and another type of opiate as an additional 
problem substance. 
Table 6 Number of poisoning deaths in which opiates were implicated (NDRDI 1998–2005)
1998 1999 2000 2001 2002 2003 2004 2005
All poisoning deaths 178 187 182 175 210 184 205 232
Poisoning deaths involving an opiate 95 102 104 98 112 93 110 125
By category:
Opiate (excluding analgesic containing an 
opiate compound) 72 81 71 71 79 63 74 93
Opiate alone (excluding methadone) 12 22 17 29 15 16 22 22
Methadone alone 8 7 6 7 6 6 11 10
Analgesic containing an opiate compound 
(alone) 9 5 13 11 9 8 12 9
Opiate with other substance(s) 52 52 48 35 58 41 41 61
Analgesic containing an opiate compound 
with other substance(s) 14 16 20 16 24 22 24 23
Source: Unpublished data from the NDRDI.
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Figure 1 Trend in the number of heroin seizures 2003–2007 (CSO 2008, 2009).
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CSO data – drug seizures
Figure 1 presents the number of heroin seizures in the years 
2003–2007, showing a steady rise since 2004.
Conclusion
The data from a range of sources indicate an increase in 
opiate availability, and a parallel increase in use and in 
treatment demand. The data also point to the serious 
consequences of opiate use, most notably the considerable 
number of deaths each year in which an opiate is involved. 
(Jean Long and Suzi Lyons)
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Solvent and volatile inhalant use in Ireland
Under the Irish Child Care Act 1991 it is an offence to sell, 
offer or make available solvents to a person aged 17 or 
under if there is reasonable cause to believe that he/she is 
likely to inhale them. 
Solvents or volatile inhalants are a diverse group of 
substances whose chemical vapors can be inhaled to 
produce psychoactive or mind-altering effects.1 These 
substances vaporise at room temperature. A variety of 
products common in the home, school and workplace 
contain volatile substances that can be inhaled (Table 1); 
however, people do not typically think of these products 
as drugs because they were never intended to induce 
intoxicating effects. Yet, young children and adolescents can 
easily obtain these toxic substances and are among those 
most likely to abuse them. 
NACD general population survey – volatile inhalant use
According to the 2006/7 survey,2 the proportion of the adult 
population who reported using a solvent or volatile inhalant 
in their lifetime was 1.9%, a small increase on the 2002/3 
fi gure of 1.7%. It was more common for men (2.3%) than 
women (1.4%) to report use of these substances. Lifetime 
use was highest among adults aged 15–24 years, at 4.2%.
Survey of school children – volatile inhalant use 
A study completed in 2004 examined the extent of tobacco, 
alcohol and drug use among primary school children aged 
11 to 14 years in Limerick City, Limerick County, Clare and 
North Tipperary (the Mid-West Region).3 Of the 1,254 
respondents to the survey questionnaire, 53 (4.2%) had 
used glue/solvents at least ‘once or twice’ in their lives. 
Forty-four out of the 53 said that they had only ever done 
this ‘once or twice’. Thirty-three of the solvent users were 
male and 20 were female.
The fourth ESPAD survey4 was conducted in 35 European 
countries during 2007 and collected information on alcohol 
and illicit drug use among 15–16-year-olds. Lifetime use of 
solvents or inhalants decreased in Ireland over three time 
points, from 22% in 1999 to 18% in 2003 and to 15% in 
2007, but remained higher than the European average (9%). 
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Solvent and volatile inhalant use in Ireland (continued)
Girls were marginally more likely to have used solvents or 
inhalants than boys, 16% compared to 14%. Half of the 
users reported that they had taken these substances three or 
more times during their life.
Volatile inhalant use among young people in the south 
east of Ireland
A recent study explored practices, social dynamics and 
effects of solvent or volatile inhalant use and suggested 
methods to deter or stop use among young people.5 This 
inquiry was part of a much larger study on drug use. The 
authors interviewed 11 males and nine females (average 
age 13.2 years) living in the south-east of Ireland about 
their solvent or volatile inhalant use. The average age of fi rst 
solvent use was 10.3 years; frequency of subsequent use 
was sporadic and opportunistic and most stopped using by 
the age of 13 years. Half of the solvent users also smoked 
cigarettes, despite the obvious danger associated with 
co-use. Solvent use was followed by initiation into alcohol 
use (average age of fi rst use 12.5 years) and then a small 
number experimented with cannabis. Most used solvents 
outdoors with their peer group and during the summer 
holidays. There were some reports of solvent use during 
school breaks.
The type of solvent used was determined by cost, access 
and place of residence. Children who lived in rural areas 
used a limited number of products, namely, wood glue, 
diesel and petrol, whereas children in urban areas used a 
wide variety of products, including Pritt Stick, methylated 
spirits, hairspray, deodorant, chrome paint, butane, nitrous 
oxide and Vicks nasal inhalant. Some products were inhaled 
using a plastic bag, others by placing the spray nozzle in 
the mouth or nostril, and others by pouring the product 
on a damp cloth and placing it over the face. Participants 
reported a variety of reasons for continuing to use solvents, 
such as to be part of the peer group, to relieve boredom, to 
experience a high, to help to deal with stress or to escape 
from reality. They reported a variety of physical effects such 
as fainting, vomiting, infl amed nostrils or headache. Some 
reported doing things following use that they would not 
normally do, such as having sex, being involved in vandalism 
or acting on a dare. All respondents knew someone who had 
died as a result of solvent use. In general, they reported that 
teachers were uncomfortable delivering information about 
drug use. They suggested that shopkeepers should not sell these 
substances to children. They also suggested that use would 
be deterred if the negative effects of these substances were 
explained and life stories were shared. The latter suggestion is 
not in line with the current evidence-based practice. 
NDTRS data – treated volatile inhalant users 
(unpublished data)
The numbers who entered treatment in the years 2003–
2007 and reported solvents or volatile inhalants as their main 
problem substance ranged between 24 and 32, with a total 
of 137 for the fi ve-year period. The vast majority (112) of 
these cases were entering drug treatment for the fi rst time. 
Just over half (53%) were male and four-fi fths were aged 
17 years or under. Only 13% lived in Dublin (possibly an 
indication of service availability in Dublin) and 70% were still 
in school. The vast majority (97%) were Irish. The solvents 
or volatile inhalants most commonly reported as a main 
problem substance were solvents (reported by 78 cases), 
nitrites (by 16), petrol (by 12) and butane (by 7), and the 
most common additional problem substances were alcohol 
and cannabis. In the same fi ve-year period 164 cases reported 
solvents or volatile inhalants as an additional problem 
substance, of whom 106 were treated for the fi rst time. 
Table 1 Type, descriptor and examples of volatile inhalants and solvents
Type Descriptor Examples
Volatile solvents Liquids that vaporise at room temperature. 
Found in a multitude of inexpensive, easily available 
products used for common household and industrial 
purposes
Paint thinners and removers
Dry-cleaning fl uids, Degreasers
Gasoline, Glues
Correction fl uids
Felt-tip marker fl uids
Aerosols Sprays that contain propellants and solvents Spray paints
Deodorants, Hairsprays
Vegetable oil sprays 
Fabric protector sprays
Gases Medical anesthetics as well as gases used in household 
or commercial products 
Butane lighters, Propane tanks
Whipped cream dispensers 
Refrigerants
Chloroform, Ether, Halothane
Nitrous oxide (laughing gas)
Nitrites Nitrites, unlike most other inhalants, act primarily to dilate 
blood vessels and relax the muscles. While other inhalants 
are used to alter mood, nitrites are used primarily as 
sexual enhancers
Amyl nitrite
Butyl nitrite
Source: US National Institute on Drug Abuse (2007). 
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Table 2 Volatile substances implicated in poisoning deaths (NDRDI 1998–2005, unpublished data)
Volatile substance Number 
of deaths
Butane, propane 12
Other substance (lighter fl uid, glue, industrial solvent, Freon, helium, aerosol spray) 10
Antiperspirant 8
Total 30
NDRDI data – deaths as a result of volatile inhalant use
The NDRDI reported 1,553 poisoning deaths in the period 
1998–2005.6 Volatile inhalants and solvents were implicated 
in 30 of these deaths (Table 2), of which 22 were in the 
under-20 age group, with nine of these in the under-15 age 
group. Only a small number of these individuals were known 
to be in drug treatment at the time of their death. More 
than one substance was implicated in 20% of the deaths; 
the other substances involved were other solvents, opiates, 
antidepressants, benzodiazepines and alcohol. The annual 
death rate remained reasonably steady over the eight-year 
period. The male to female ratio was approximately equal 
(at 1.1:1). The majority (76.6%) of these individuals, 
including all of the under-15s, were not alone at the time 
of their death, and 56.6% of the deaths occurred in a 
private dwelling.
Solvent and volatile inhalant use in Ireland (continued)
Conclusion
The majority of volatile inhalant or solvent users are teenage 
boys and girls who are still in school. Only a small number 
seek treatment for problematic use of these substances. 
Nonetheless, there are a number of fatalities each year as a 
result of inhaling these everyday household products.
In early 2006, the Justice Department of the Scottish 
Executive commissioned a review of the available evidence 
on volatile substance abuse among young people in 
Scotland.7 The topics covered in the review were the 
prevalence and nature of volatile substance abuse, successful 
prevention of such abuse and effective communication of 
information and messages about such abuse. The authors 
reported that the available evidence was limited. Their 
fi ndings indicate that:
Volatile substances should be included in drug • 
education and given the same priority as other 
illicit substances. Research is necessary to determine 
the appropriate age at which to introduce volatile 
inhalant education and identify the message(s) that 
should be given. This is because research carried 
out in England found that providing education to 
children about the dangers of volatile inhalant use 
had in some cases encouraged experimentation with 
volatile substances.
Parental involvement is paramount in deterring • 
children and teenagers from drug experimentation 
and continued use. Again, this means that parents 
must be aware of the dangers of volatile substance 
use, and should class these substances in the same 
category as other illicit drugs (such as heroin, cocaine 
or ecstasy).
Manufacturers of volatile inhalants and solvents must • 
be responsible to ensure they do all that is possible to 
deter abuse of these substances. This includes putting 
warning messages on packaging about the dangers 
of inhalation of these substances and designing 
containers that deter inhalation of the product.
Existing legislation on the selling of volatile inhalants or • 
solvents to minors needs to be reviewed and enforced. 
Very often volatile inhalants and solvents are • 
classed differently to other illicit substances and are 
therefore not given the same priority at a policy-
making level. As a result, these substances are not 
always specifi cally addressed in strategies, education 
programs, control and treatment. 
(Simone Walsh and Jean Long)
National Institute on Drug Abuse (2007) 1. InfoFacts: 
inhalants. Washington DC: NIDA, Department of Health 
and Human Services. Accessed 11 November 2009 at 
www.nida.nih.gov/PDF/Infofacts/Inhalants07.pdf 
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Coolmine launches three-year 
strategic plan 
Coolmine Therapeutic Community (CTC) launched its 
strategic plan for 2009–2011 in September 2009.1 The 
plan was offi cially launched by John Curran TD, Minister 
for State with responsibility for drugs strategy. Coolmine 
Chief Executive Paul Conlon spoke of the challenges facing 
services providing drug treatment and rehabilitation. 
Recent developments in Coolmine refl ect the community’s 
continuing commitment to the provision of a continuum 
of care, and to a vision of recovery which emphasises an 
enhanced quality of life rather than mere abstinence from 
drugs. The chief executive’s overview lists Coolmine’s 
achievements of note under the 2006–2008 strategy:
creation of formal client consultation and • 
participation structures;
i• nitiation of a stabilisation day programme for active 
drug users in partnership with other service providers;
establishment of clinical governance structures • 
and procedures, including the creation of a limited 
detoxifi cation service within its residential facilities;
provision of full-time staff cover in residential facilities;• 
reduction in the length of stay in all three residential • 
facilities to an average of six months;
change of institutional culture and styles at Ashleigh • 
Hose to refl ect the fact that the facility caters for 
mothers and children;
provision of fi ve community aftercare houses to • 
facilitate clients who have completed primary 
treatment programmes;
establishment of a part–time career guidance • 
and counselling service and enhanced use of the 
Community Employment scheme to benefi t clients;
completed refurbishment of two of its main facilities • 
and commencement of work on the third; and 
creation of an improved fundraising strategy.• 
The new strategy identifi es and links its two key objectives:
 To consolidate and develop existing quality services
establish an advisory group to ensure clinical governance, • 
ongoing training and best practice is achieved;
increase resources and training to ensure that • 
existing programmes are accessible to a greater 
range of people; 
develop a volunteer programme and foster stronger • 
links with external service providers; and 
develop strategic partnerships with a number of • 
housing providers to ensure that clients have the best 
opportunities for accommodation.
To build a strong and sustainable organisation 
complete capital works; • 
improve internal communications structures, and • 
implement an effective IT strategy; 
develop an external communications strategy to raise • 
Coolmine’s profi le and to aid fundraising efforts; and 
explore potential development opportunities at • 
Coolmine Lodge site for housing units or a residential 
detoxifi cation unit.
(Vivion McGuire)
Coolmine Therapeutic Community (2009) 1. Supporting 
people in changing times: strategic plan 2009 to 2011. 
Dublin: Coolmine Therapeutic Community. www.
coolminetc.ie
drugnet 
IRELAND
Minister Curran with Declan Arthur and Paul Conlon of the Coolmine Centre at the offi cial launch, earlier this year, 
of the Mother and Child Facility at Ashleigh House
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Provision of social support for people 
with drug addictions
The Comptroller and Auditor General recently reported 
on his examination of publicly funded treatment and 
rehabilitation services for people with drug addictions.1 
Issue 31 of Drugnet Ireland presented the report’s fi ndings 
with respect to drug treatment.2 This article presents the 
fi ndings with respect to provision of support for people 
seeking, receiving or following treatment for addiction in 
the key areas of 
accommodation• 
education, training and employment• 
childcare• 
Accommodation
Drawing on data from the National Drug Treatment 
Reporting System (NDTRS), the report states that some 7% 
to 8% of those entering or re-entering treatment each year 
are recorded as homeless, and a further 3% to 4% are in 
some form of unstable accommodation. Being homeless or 
living in unstable accommodation can undermine the gains 
that would be expected from engaging in drug treatment.3
The report recommends that separate accommodation be 
provided for drug users in treatment and for those who 
have completed treatment and wish to pursue a drug-
free lifestyle; this would support recovering drug users by 
reducing the risk of relapse. The report highlights the role of 
step-down facilities in supporting those who have completed 
treatment, and notes that the Health Service Executive (HSE) 
currently funds 29 step-down beds for people recovering 
from drug addiction. It also notes that demand for 
accommodation places for recovering drug users far exceeds 
the number of beds available. 
An evaluation of one of the HSE step-down projects showed 
the positive outcomes that can be achieved by recovering 
drug users.4 Of 12 former clients who completed that 
programme, six were living independently, two were 
living with a family member or a partner and four were 
living in further transitional housing. Self-reporting by 
these clients and their key workers suggested that they 
were no longer abusing drugs and were in education, 
training or employment. 
The C and AG report highlights the importance of collecting 
data on the percentage of people using step-down facilities 
who progress to independent living. The report also 
calls for national monitoring of waiting times for access 
to transitional or long-term accommodation by those 
undergoing rehabilitation. 
Education, training and employment
The report notes that, consistently, around 60% of those 
commencing treatment report that they are unemployed, 
20% report being in paid employment and 4% report 
participating in FÁS or other training schemes. Since the 
introduction of the FÁS Special Community Employment 
(CE) scheme designed to provide vocational training for 
recovering drug users, there has been a consistent shortfall 
in the uptake of places, with a decline from 90% in 2004 
to 83% in 2007. The reasons for this decline are not clear 
and, as the report points out, the decline ‘occurred at a 
time when the numbers in drug treatment were increasing’. 
The report notes that FÁS now draws up Individual Learner 
Plans for people registering with them and suggests that this 
approach could potentially fi t well with the individual care 
plans that might be developed with key workers to help those 
in drug treatment access structured and suitable education 
and training interventions at the appropriate time. The report 
also suggests that the effectiveness of projects under the 
Special CE scheme should be evaluated. 
Childcare 
According to the report, 15% of those entering treatment 
for drug addiction in 2007 were living with dependent 
children. The report notes that the current provision of 
childcare services for drug misusers is limited, in that: 
the Health Service Executive does not provide • 
childcare facilities on most addiction service 
premises;
community and voluntary groups provide limited • 
childcare facilities; and 
very few Special CE projects provide childcare for • 
participants. 
The report cites the following recommendations made by 
the Working Group on Drugs Rehabilitation: 
An audit of gaps in childcare provision for children • 
of drug users should be undertaken.
Childcare services for children of drug users should • 
focus on the developmental needs of children. 
Parenting programmes for drug users should be • 
developed and implemented. 
The report concludes by proposing a means by which these 
issues can be acted on within the broader framework of 
treatment and rehabilitation: 
Protocols developed for interagency work should • 
cover referral and reporting to social support 
providers, e.g. local authority housing department 
and FÁS.
Waiting times for accessing social support services • 
should be formally monitored and reported on.
Comprehensive care planning would help to identify • 
the extent to which those receiving treatment 
require assistance with accommodation. 
(Martin Keane)
Comptroller and Auditor General and Department of 1. 
Community, Rural and Gaeltacht Affairs (2009) Drug 
addiction treatment and rehabilitation. Special report, 
Value for Money 64. Dublin: Offi ce of the Comptroller 
and Auditor General. www.audgen.gov.ie
Long J (2009) Comptroller and Auditor General report on drug 2. 
treatment. Drugnet Ireland, (31): 13–14.
Keane M (2007) 3. Social reintegration as a response to drug 
use in Ireland. HRB Overview Series 5. Dublin: Health 
Research Board.
Juniper Consulting (2008) 4. Step-Down programme George’s 
Hill: evaluation report. Dublin: Focus Ireland. 
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Blueprint drugs education: ﬁ ndings 
from an evaluation
The Blueprint drugs education programme is an evidence-
based, multi-component programme that was piloted in 
23 schools in England during the spring terms of 2004 and 
2005. The programme provided drug education lessons to 
children in Year 7 (when they were aged 11) and Year 8, 
complemented by four additional components: parents, 
media, health policy and community. The programme 
aimed to equip pupils with the knowledge and experience 
necessary to make informed choices about drug use. This 
article summarises the main fi ndings from the responses of 
pupils and parents to the programme and the results of a 
prevalence survey that measured changes in behaviour and 
attitudes of pupils towards substance use.1 
The evaluation
Pupils in the 23 schools completed a prevalence survey, 
which measured their attitudes and behaviours in relation 
to drug use, and an impact survey, which measured their 
reaction to the Blueprint programme. Parents or carers 
completed a survey which examined their awareness and 
opinions of Blueprint. A smaller sample of pupils from six 
local schools who received drugs education through Personal, 
Social, Health and Economic (PSHE) education classes was 
surveyed using some of the same measures used to assess 
the Blueprint pupils. Findings from this smaller sample are 
presented to provide context to the work; these schools do 
not act as a comparison group to the Blueprint schools. 
Pupils’ and parents’ responses to Blueprint
The vast majority of Blueprint pupils reported that • 
the lessons were an important source of information 
about drugs. 
Pupils enjoyed the format of the lessons, in particular • 
the active teaching methods, such as role play. 
Pupils learnt some of the skills needed to deal with • 
situations in which they might be offered drugs. 
Pupils demonstrated good recall of drug knowledge. • 
Parents approved of their children being taught • 
about drugs at school. 
The Blueprint materials format was effective in • 
engaging some parents in drug education and 
the parents who took part felt that the material 
increased their knowledge and helped them talk to 
their children about drugs. Overall, it was diffi cult to 
engage parents with the programme. 
Prevalence, attitudes, and drug-use norms
Among Blueprint pupils, prevalence of smoking, • 
drinking and drug use increased between Year 7 
and Year 10. 
A higher level of drug taking was associated with • 
previous use, truancy and exclusion. 
Many pupils overestimated the number of their peers • 
who smoked and drank alcohol; fewer overestimated 
the number who used drugs. 
The perception by pupils of a high prevalence rate • 
of drug use, smoking and alcohol use among their 
peers was associated with truancy, exclusion, being 
older and being a girl. 
Perceived acceptability of smoking, drinking alcohol • 
and drug use increased between Year 7 and Year 10. 
Drinking alcohol was considered more acceptable 
than smoking or taking drugs. 
Findings from local school data
Pupils from local schools were positive about drug • 
education they received as part of PSHE lessons. 
Almost half of pupils cited PSHE lessons on drug • 
education as important sources of information, and 
the content and delivery of lessons were rated highly. 
Pupils demonstrated high recall of drug knowledge. • 
Prevalence of smoking, drinking and drug use • 
increased between Year 7 and Year 10. 
Parents approved of their children receiving drugs • 
education at school. 
According to the evaluation team, ‘The original design 
of the Blueprint evaluation was not suffi ciently robust 
to allow an evaluation of impact and outcomes, and 
consequently the evaluation did not draw any conclusions 
on the effi cacy of Blueprint in comparison to existing drug 
education programmes.2 ... Instead, it was decided that 
the implementation of the programme would be the main 
focus of the evaluation, and that the ratio of 23 Blueprint 
schools and six local schools would be kept so that large-
scale implementation could be assessed.’ While it was 
still planned to draw some comparisons between the two 
samples, ‘academic and statistical reviews concluded that to 
present the data in this way would be misleading, given that 
the sample sizes are not suffi cient to detect real differences 
between the groups’. Instead, fi ndings from the six local 
schools were presented to provide context to the work; 
these schools did not act as a comparison group to the 
Blueprint schools. 
(Martin Keane)
Blueprint Evaluation Team (2009) 1. Blueprint drugs 
education: the responses of pupils and parents to the 
programme. London: Home Offi ce. www.ism.stir.ac.uk/
pdf_docs/Blueprint/fi nalreport.pdf
Two additional reports of the Blueprint evaluation, 2. 
the delivery and practitioner reports, were released 
in November 2007 and are available at http://drugs.
homeoffi ce.gov.uk/publication-search/blueprint/dpreports/
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Van Hout completed a comprehensive study of drug and 
alcohol use among adolescents in the south east of Ireland 
from the standpoint of young people, parents and service 
providers. This article presents a summary of the fi ndings in 
relation to each of the three groups, as published in separate 
journal articles.
Substance use reported by adolescents
The author completed semi-structured interviews with a 
random sample of 220 children aged 15–17 years from 
schools and youth training centres in the area.1 Just under 
one-quarter of the respondents reported ever using an illicit 
drug, and the majority who had tried drugs were boys. 
Almost all said that they had been offered drugs and that 
drugs were easily available in urban areas. The majority 
believed that drug use would increase in the future in the 
area. They said that neither the police nor the schools took 
action to stop dealing or drug use in public. Drugs were 
purchased over the phone and could even be delivered to 
the schoolyard. 
Cannabis was the most common drug used and, excluding 
alcohol and volatile inhalants, was the fi rst drug used by 
the majority. A small number reported that ecstasy or 
amphetamine was their fi rst drug. Alcohol was usually 
consumed alongside illicit drugs. Cannabis was perceived 
as a safe drug, and cocaine, heroin and speed as dangerous 
drugs. Most took drugs because they were curious or bored, 
or their friends were taking them. Some said that drugs 
helped them to relax or gave them a buzz. The majority 
were aged between 10 and 15 years when they took their 
fi rst drug, which was usually given by a friend or older 
sibling; the initial occasion was unplanned; and almost half 
felt ill after taking the drug. A small number reported that 
they clubbed together with friends to buy drugs. 
Some respondents reported that they controlled their 
drug use to prevent addiction, overdose, or other 
physical symptoms. Very few were worried about the 
legal consequences of illicit drug use. Some of the older 
respondents reported that they had ceased illicit drug use 
because drugs had lost their appeal, or they had experienced 
negative effects, or they preferred alcohol. The respondents 
who had never taken drugs gave the following reasons 
for their decision: drugs are dangerous, they have side 
effects, and/or drug use could be diffi cult to control. Some 
respondents were afraid of their parents’ reaction if they 
were discovered using drugs. 
Parents’ views
To ascertain parents’ views on youth substance use, the 
author conducted semi-structured interviews with a 
convenience sample of parents (34 mothers and 21 fathers) 
of adolescent children attending three rural schools.2 The 
interviews included questions relating to the parents’ 
perceptions of youth drug and alcohol use (in terms of both 
recreational and problematic use in their communities), 
drug availability, perceptions of risk, types of settings for 
adolescent substance use, service provision and drug 
information. The parents were not questioned about their 
own children but about youth in general. 
The results suggest that the parents were concerned about 
the increased exposure to drugs among youth in local rural 
communities. The majority of parents were aware of youth 
alcohol use, they were concerned about all drugs, they 
were not aware of specifi c differences in drug-related risk, 
and they had diffi culty comprehending harm-reduction 
principles. Most parents recognised the need for greater 
parental monitoring of their children’s free time and 
improved parent–child discourse, as well as the need for 
more widespread drug education, and the provision of 
visible and accessible services and support for the families of 
problem substance users. 
The author concluded that life in contemporary rural Ireland 
is infl uenced by dominant social changes in terms of the 
normalisation of alcohol and drug use in youth subcultures. 
This is facilitated by increasing fragmentation of traditional 
rural family norms and values, emerging acceptability of 
alcohol and drug use in recreation time and the increasing 
availability of alcohol and drugs. 
Service providers’ views 
The author also explored the perspectives of 78 service 
providers in the area on youth substance use and current 
service provision.3 The service providers worked in youth, 
community, addiction, education or health services. 
As did the parents and the adolescents, the service providers 
believed that illicit drugs and drug use had become a normal 
aspect of society in the area. They said that use had increased 
because the availability of drugs had increased, young people 
had more disposable income and greater freedom, and their 
free time was not monitored by parents. They believed that 
young people had a positive attitude to alcohol use and a 
facilitating attitude to drug use, and that this encouraged 
experimentation. In addition, children had more knowledge 
about the effects of individual drugs and the effects of mixing 
them. Drug use included use of solvents and inappropriate 
use of prescription medication. The service providers said 
that teachers were trying to control drug dealing and use in 
the schoolyard, whereas the young people felt that there was 
not enough control in the yard. 
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The service providers reported that children are introduced 
to alcohol at a young age and observe their parents and 
siblings drinking to excess. They cited poor parental 
monitoring and unstructured leisure time as contributing 
factors. Young people were observed purchasing and sharing 
drugs among close peers or best friends. Drug and alcohol 
use occurred in fi elds, on the streets or at friends’ houses. 
Children as young as 10 years were known to use drugs, 
and boys were more likely than girls to experiment. Young 
people had developed an informal hierarchy of drugs, 
according to their perceived level of harm, with heroin at the 
top of the scale and cannabis at the bottom. Young people 
thought that heroin was safe if smoked and that cannabis 
was as safe as cigarettes. 
According to the service providers, most children 
experiment with drug use and mature out of it, but children 
experiencing family problems and disruption are more likely 
to develop problem drug or alcohol use. The providers also 
pointed out that adolescent diagnostics and services in the 
south east of Ireland are based on adult models. 
(Jean Long)
Van Hout MC (2009) Drug and alcohol use among rural 1. 
Irish adolescents: a brief exploratory study. Drugs and 
Alcohol Today, 9(1): 20–26.
Van Hout MC (2009) Youth alcohol and drug use in rural 2. 
Ireland: parents’ views. Rural and Remote Health, 9: 1171.
Van Hout MC (2009) An illustrative picture of Irish 3. 
youth substance use. Journal of Alcohol & Drug 
Education, 53(1): 7–14.
Adolescent substance use in south-east Ireland (continued)
Substance misuse in the HSE South 
Eastern Area 
The Health Service Executive (HSE) South published the 
report Data co-ordination overview of drug misuse 2008 in 
August 2009.1 The report comprises sections relating to 
treatment services, substance-related offences and cases dealt 
with by the Probation Service in the HSE South Eastern Area. 
The section on treatment services analyses data collected 
from statutory and voluntary drug and alcohol treatment 
agencies, acute general hospitals and psychiatric hospitals 
in the HSE South Eastern Area. Data from the drug and 
alcohol treatment services are returned to the National Drug 
Treatment Reporting System in the Health Research Board. 
The total number of individuals seeking treatment in 2008 
was 2,686, a decrease of 265 on the 2007 fi gure. Some 
60 concerned persons (family members or close friends of 
substance users) contacted treatment services in the south 
east in 2008.
The combined total of continuous care clients and new 
referrals who were treated was 2,376. Of these: 
68% were male and 32% were female.• 
13% were under the age of 20, and 41% were aged • 
between 20 and 34. 
Alcohol (62%) was the most common main problem • 
substance for which treatment was sought, followed 
by heroin (12%), cannabis (11%), and cocaine (5%). 
Cannabis, which had been second in this ranking for 
a number of years, was overtaken by heroin in 2008.
The numbers seeking treatment for alcohol and • 
cannabis have decreased annually from 2007 
onwards. Up to 2007, cocaine fi gures were rising, 
but the numbers seeking treatment for cocaine 
decreased in 2008. The numbers seeking treatment 
for heroin, MDMA, amphetamines and volatile 
inhalants increased.
A total of 1,972 clients exited the services in 2008. Less 
than half (44%) of these clients completed treatment; 27% 
refused further sessions or did not return for subsequent 
appointments; 13% did not wish to attend further sessions 
as they considered themselves to be stable; 11% were 
transferred to another site for further treatment; 4% exited 
because of non-compliance, 1% exited for other reasons, 
and 0.6% died. 
The client’s condition on discharge was classifi ed by service 
providers as stable if they had responded to treatment, and 
unstable if they had not responded. Of the 1,972 cases 
analysed, 1,347 (68%) were stable on exit from the services, 
597 (30%) were unstable, the condition of 17 (0.9%) was 
classifi ed as ‘not known’ and 11 (0.6%) had died.
Data presented in this report are useful for planning future services. 
(Anne Marie Carew)
1. Kidd M (2009) Data co-ordination overview of drug misuse 
2009. Waterford: HSE South. 
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Mental health and young people: 
a review of CBT-based interventions
The recently published results of a systematic review 
shed some light on what works in reducing or preventing 
mental health problems among young people.1 One of the 
questions addressed in the review was: 
Are secondary school-based mental health 
interventions based on cognitive behavioural 
techniques effective in preventing or alleviating 
depression, anxiety and suicidality among 
young people? 
Following an extensive search of a number of relevant 
databases, repeated screening of thousands of studies 
and an assessment of the quality of potential studies for 
synthesis, 17 randomised controlled trials (RCTs) were 
included in the fi nal synthesis. All the interventions were 
based on techniques derived from cognitive behavioural 
therapy (CBT), and were delivered to either small groups or 
entire classes. The authors point out that the CBT approach 
is primarily based on Beck’s cognitive model of depression, 
which focuses primarily on the relationships between 
cognitions, feeling and behaviours.2 
All the studies included in the review evaluated CBT 
interventions for effectiveness in reducing or preventing the 
onset of the symptoms of a range of emotional disorders. 
None presented data on the impact of CBT interventions on 
suicidal thoughts or behaviours, and none stated that suicide 
prevention had been an explicit aim of the intervention. 
The interventions taught students a variety of techniques 
for problem solving and coping, including assertiveness 
training, relaxation, negotiation, positive thinking and 
communication. Interventions aimed at reducing anxiety 
focused on social skills training. 
Findings on effectiveness of CBT interventions
Impact of CBT on depression outcomes
CBT interventions were effective in reducing depressive 
symptoms up to three months after the intervention had 
fi nished. The effect remained positive, although insignifi cant, 
at six- and twelve-month follow-up. Universal interventions 
were shown to improve depressive symptoms up to four 
weeks after delivery. Indicated interventions were shown 
to improve depressive symptoms up to six months after 
delivery. No evidence of harm was detected in any of the 
analysis. Interventions delivered by a member of school staff 
were found to be effective, while those delivered by external 
providers were not. Interventions of 10 or more sessions 
were effective up to three months post intervention. 
Shorter interventions, up to nine sessions, were found 
to be ineffective. 
Impact of CBT on anxiety outcomes
CBT interventions were found to be effective in reducing 
anxiety immediately post intervention, and at six-month 
follow-up. There was insuffi cient data to evaluate the 
effectiveness of interventions delivered by internal school 
staff. Interventions delivered by external providers were not 
shown to be effective in reducing anxiety. Interventions 
of up to nine sessions were effective at six-month follow-
up. Interventions of 10 sessions or more were found to be 
effective immediately post-intervention. 
Recommendations for practice
The authors make a number of recommendations that may 
be useful to those wishing to implement preventive mental 
health programmes in secondary schools. Providers should 
consider the use of CBT-based interventions for reducing 
depression and anxiety levels. Given the uncertainties about 
the long-term benefi ts of universal interventions, efforts to 
prevent depression in young people might best be directed 
towards indicated interventions. Providers of preventive 
mental health services to young people should: 
consider using adequately trained and supported • 
school staff to provide CBT-based interventions to 
young people;
consider providing programmes of 10 or more • 
weeks’ duration; and
be aware of, and consider monitoring, potential • 
adverse effects (i.e. stigma associated with mental 
health problems).
Providers of preventive mental health services to young 
people who are considering providing universal, rather 
than indicated, interventions should evaluate the impact 
of the intervention on high- and low-risk groups. Providers 
implementing indicated interventions may wish to monitor 
any potential adverse effects due to stigma associated with 
mental health problems. While no studies of indicated 
prevention reported adverse outcomes, such as bullying, 
The authors warn of ‘the potential risk that participants 
identifi ed as receiving such interventions may suffer 
adversely due to the social stigma attached to suffering 
from an emotional or mental health problem’.
(Martin Keane)
Kavanagh J, Oliver S, Caird J, Tucker H, Greaves A, 1. 
Harden A et al. (2009) Inequalities and the mental 
health of young people: a systematic review of secondary 
school-based cognitive behavioural interventions. London: 
University of London, EPPI-Centre.
Beck AT (1974) The development of depression: a 2. 
cognitive model. In: Friedman R and Katz M (eds) 
Psychology of depression: contemporary theory and 
research. Washington, DC: Winston-Wiley. pp. 3–27.
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Physical activity as part of adolescent 
addiction treatment
Van Hout assessed the perception of social context and 
activity scales of adolescent substance abusers following 
participation in a physical activity intervention during 
residential drug treatment.1 The increase in perception 
of social context value was measured by increased social 
interaction, group identifi cation, trust, co-operation and 
social growth. The increase in perception of activity value 
was measured by increased enjoyment, self-effi cacy, skill 
acquisition and confi dence. The sample (n=47) was assessed 
on entry to treatment, on completion of treatment, at six 
weeks after treatment and at six months after treatment, 
using mean, standard deviation, and t-tests. 
Participants were aged between 12 and 20 years, and 63% 
were male. In general, the overall mean scores for perception 
of social context value increased between entry to and 
completion of the treatment program decreased marginally 
six weeks after treatment, and returned to baseline levels 
after six months in aftercare. A small signifi cant positive 
difference was recorded between entry and six weeks after 
treatment p = 0.04). 
Perception of activity value increased between entry to and 
completion of the treatment program, increased again at six 
weeks after treatment, and decreased to below the baseline 
level six months following discharge. Positive signifi cant 
differences were recorded between entry and six weeks 
after treatment (p = 0.02). This research illustrates the 
positive potential of physical activity as part of an adolescent 
residential treatment programme, and in the fi rst six weeks 
following discharge. It notes that it was diffi cult to sustain 
the long-term benefi ts, and suggests that this aspect of the 
intervention needs to be explored. 
(Jean Long)
Van Hout MC (2008) Perception of social context and 1. 
activity following participation in a physical fi tness 
intervention during residential adolescent addiction 
treatment. American Journal of Recreation Therapy, 
7(4): 27–45.
A recent study determined the prevalence and correlates 
of depression, alcohol abuse and suicidal ideation among 
students in two universities – Trinity College Dublin and 
University College Dublin.1 While university students around 
the world are vulnerable to depression, alcohol abuse and 
suicidality, there are three reasons for hypothesising that Irish 
students are at unusually high risk. First, the prevalence of 
depressive disorder in urban Ireland is high; second, Ireland 
has the third highest per capita consumption of alcohol in 
the EU and the highest rate of binge drinking; and third, the 
suicide rate among young Irish adults has increased and a 
large proportion of this age group is in full-time education.
Questionnaires were emailed to 539 pre-fi nal year medical 
and business students, of whom 338 (63%) responded. 
The Beck Depression Inventory (BDI) was used to measure 
depression and suicidality, and the CAGE screening 
questionnaire2 to assess alcohol abuse in the past month. 
Depression in the previous month was reported by 14% 
of students and was associated with lower social support 
and a greater number of stressful life events. Four per cent 
reported suicidal thoughts without intent, and 2% reported 
serious suicidal ideation. All suicidal ideation correlated 
positively with stressful life events and negatively with social 
support. A quarter of students scored 2 or more on the 
CAGE test, indicating an alcohol use disorder, with business 
students more likely than medical students to score at this 
level. Serious suicidal ideation correlated positively with 
CAGE total.
The variable most strongly correlated with depression, 
alcohol abuse and suicidal ideation was social support; 
social support appeared to be protective; for instance, as 
social support increased, depression decreased. However, 
the cross-sectional design of this study leaves the question 
of causality unanswered; it is possible that depressed 
participants underestimated their true level of social support. 
The authors conclude that students would benefi t from an 
expansion of mental health and alcohol education, and of 
psychosocial services in universities. Further research could 
use more robust methods of diagnosis and more detailed 
evaluation of the demographic and psychosocial factors that 
predict serious mental illness. 
(Deirdre Mongan)
Curran T, Gawley E, Casey P, Gill M and Crumlish N 1. 
(2009) Depression, suicidality and alcohol abuse among 
medical and business students. Irish Medical Journal, 
102(8): 249–251.
CAGE is an acronym formed from the initial letters of the 2. 
four key words/phrases in the screening questionnaire – 
Cut down, Annoyed, Guilty, Eye-opener.
Mental health issues and alcohol abuse 
among college students
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Addiction Response Crumlin (ARC) published its strategic plan for 2009–
2012 on 31 July 2009.1 Commissioned by the ARC board of management 
in the autumn of 2008 during times of economic uncertainty, the plan 
was launched by the Lord Mayor of Dublin Emer Costello. ARC 
co-ordinator Susan Collins spoke of the uncertain times ahead for all 
service providers and the challenges that may arise. 
Four strategic priorities are identifi ed for the three-year period of the 
plan, which will allow ARC to measure its achievements effectively:
building organisational capacity;• 
sustaining and strengthen-ing quality service;• 
fostering effective external relationships; and• 
ensuring quality governance and accountability.• 
Ms Collins, in consultation with the board of management and staff, 
will set up a high-level steering group to oversee the implementation 
of the strategy and monitor it into the future. At the end of the three-
year period this group will evaluate and communicate the strategy 
achievements.
To respond effectively to the needs of problem drug users, their families 
and the local community in Dublin 12, ARC will need to:
keep existing baseline services in place;• 
retain current staff team; • 
maintain high standards and quality of treatment and care;• 
ensure that innovative and fl exible approaches within services • 
are supported; and
maintain and strengthen relationships with community and • 
state bodies.
For further information on ARC services, please visit the website at 
www.addictionresponsecrumlin.ie
(Vivion McGuire)
Addiction Response Crumlin (2009) 1. Strategic plan 2009–2012. 
Dublin: ARC. 
ARC strategic plan 2009–2012
L to r: Dr Ailbhe Smyth, Cllr Ruairi McGinley, Lord Mayor Cllr Emer Costello, Cllr Eric Byrne, Ms Aoife Fitzgerald 
Co-ordinator D12 LDTF, Ms Susan Collins and Mr Jimmy Norman of ARC
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MQI annual review 2008
The Merchants Quay Ireland (MQI) annual review for 2008 
was launched on 29 September 2009 by Mr Ryan Tubridy.1 
MQI’s needle-exchange service recorded that the number of 
client visits in 2008 remained steady at just under 40,000; 
however, almost 1,000 of those visits were by new clients. 
The report also highlights a continuing high level of demand 
for homeless services, with a 4% increase in the number of 
meals provided for homeless people. There was a decrease 
in the numbers seeking help from MQI’s primary health care 
services, resulting from a decision to limit the number of 
attendees and give adequate time to those presenting.
In 2008 MQI completed the implementation of a national 
prison-based addiction counselling service to 13 prisons 
and is providing in excess of 1,000 counselling hours per 
month and working with 440 prisoners. With the support 
of the Vodafone Ireland Foundation, MQI has expanded its 
family support service, which now includes a confi dential 
helpline, counselling, support groups and drug education 
awareness for families. In late 2008 MQI in association with 
the Midland Regional Drugs Task Force introduced the 
Midlands Family Support and Community Harm Reduction 
Service, providing outreach and working with families of 
those actively using drugs.
The types of service offered by MQI and the numbers of 
people accessing them in 2008 are shown below.
(Vivion McGuire)
1. Merchants Quay Ireland (2009) Annual review 2008. 
Dublin: MQI. 
Service Type of intervention No. of participants Outcomes
Needle-exchange and 
health-promotion services
Promoting safer injecting techniques 
HIV and hepatitis prevention
Safe sex advice
Information on overdose
Not available 
(1,000 new clients)
904
Not available
Not available
Stabilisation services Methadone substitution
Supportive day programmes
Gateway programme
Counselling
20
Not available
Not available
382
Not available
Not available
Not available
Not available
Settlement service Assist service users to access interim and 
long-term accommodation
34 (monthly average) Not available
Integration programmes Access to transitional accommodation 
Ballymount House and Athlone for up 
to 24 weeks 
Group and one-to-one therapeutic sessions
15 11 clients moved 
to longer-term 
accommodation
Training and work 
programmes
FÁS Community Employment scheme 124 32% secured 
permanent 
employment or 
moved to further 
education
High Park 17-week, drug-free residential programme 
including individual counselling, group 
therapy, educational groups, work 
assignments and recreational activities
59 (of whom 18 
were admitted for 
detoxifi cation)
14 completed 
detox
St Francis Farm Therapeutic facility offering a 6–12-month 
programme
29  14 completed 
three months 
or more
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From Drugnet Europe
Keeping pace with a shifting drug phenomenon
Cited from Drugnet Europe, No. 68, October–
December 2009 
‘Effective and evidence-based policies are increasingly 
necessary as challenges in the drugs fi eld grow ever more 
complex’, said EMCDDA Director Wolfgang Götz, in his 
message launching the Annual report 2009: the state of the 
drugs problem in Europe. A common theme running through 
this year’s report is the need for our vision to keep pace with 
an ever-shifting drug phenomenon and that well-conceived 
interventions can deliver real benefi ts and value.
Highlighted in particular is Europe’s increasingly volatile 
synthetic drug market, where ‘highly innovative’ suppliers 
circumvent drug controls by offering alternatives to 
controlled drugs. While this practice is not new, what is new 
is the wide range of substances now on offer, the growing 
use of the Internet and the aggressive and sophisticated 
marketing of products. The diffi culties of ‘hitting a moving 
target’ are described in the report.
As regards the more traditionally used drugs, ‘overall, we are 
not seeing major increases and, in some areas, trends appear 
to be downwards’, said Götz. Indicators for amphetamine 
and ecstasy use, for example, still suggest an overall steady 
or declining situation. And, new data confi rm a continued fall 
in cannabis use, particularly among young people. However, 
he added: ‘cocaine and heroin continue to maintain a fi rm 
hold on Europe’s drug scene’. And polydrug use is now 
widespread in Europe, increasing risks and complicating the 
delivery of treatment.
Drugs in focus – policy brieﬁ ng
Extract from Issue No. 20: Responding to drug driving 
in Europe 
Many of the accidents and deaths that occur on European 
roads are caused by drivers whose performance is impaired 
by a psychoactive substance. Alcohol alone is estimated to 
account for up to 10 000 road deaths a year in the European 
Union, one quarter of all road deaths. No comparable fi gures 
are available for road accidents related to illicit drugs and 
psychoactive medicines, though these have been receiving 
increasing attention over the past decade.
The complex issue of drug driving is currently being 
investigated by DRUID, a major EU project that began in 
2006 and will continue until 2010. DRUID aims to provide 
a solid basis for harmonised, EU-wide regulations for driving 
under the infl uence of alcohol, drugs and medicine. Until 
then, this policy briefi ng summarises the key issues facing 
policymakers and describes developments across Europe that 
may assist decision-making on the topic.
Key issues at a glance
Reports of drug driving incidents often receive much 1. 
media attention. But, few countries have reliable 
statistics on the prevalence of driving under the 
infl uence of drugs.
Obtaining sound scientifi c evidence on behavioural 2. 
effects, prevalence and accident risk is diffi cult with the 
available data. Many of the studies have small samples 
and it is often diffi cult to generalise from their results.
Refl ecting the scientifi c debate about the precise effects 3. 
of the substances, the legal defi nition of the offence of 
driving under the infl uence of drugs differs among EU 
Member States.
Various psychoactive medicines, which might or might 4. 
not be legally prescribed and consumed, can impair 
driving skills.
Currently, police experience considerable diffi culty with 5. 
the accurate and rapid identifi cation of drug driving at 
the roadside.
The effectiveness of information campaigns to prevent 6. 
drug driving is open to question. Key audiences may not 
be hearing the message, or they may be ignoring it.
Conclusions and policy considerations
Surveys on the prevalence of drugs in drivers need to 1. 
be conducted in all EU Member States. Testing all drivers 
involved in a fatal accident for drug and alcohol use 
would provide an important source of information for 
monitoring the problem.
New guidelines on study design are available that take 2. 
into account the variety of legal and practical constraints 
in different countries. They aim to improve comparability 
among studies and may facilitate exchange of 
best practice.
Policymakers should consider the latest scientifi c 3. 
information available when designing legal responses. 
The level at which a driver will be deemed in breach 
of the law should be clear for all stakeholders and 
the public.
National laws and their enforcement need to strike a 4. 
balance between concerns about ensuring road safety 
and the therapeutic needs of individuals.
Legal frameworks require review, as even with the 5. 
limitations of existing testing methodology, more 
effective procedures are possible. And, new options are 
likely to become available.
Prevention campaigns should target specifi c risk groups 6. 
and substances; be based on scientifi c evidence; and 
rigorously evaluated for impact on behaviour and attitudes. 
Drugnet Europe is the quarterly newsletter of the European 
Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA). Drugs in focus is a series of policy briefi ngs 
published by the EMCDDA. Both publications are available 
at www.emcdda.europa.eu.
If you would like a hard copy of the current or future issues 
of either publication, please contact: 
Alcohol and Drug Research Unit, Health Research Board, 
Knockmaun House, 42–47 Lower Mount Street, Dublin 2. 
Tel: 01 2345 127; Email: adru@hrb.ie.
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In brief
On 26 June 2009 the International Society for the Study 
of Drug Policy (ISSDP) published a selection of papers 
from its second annual conference, held in Lisbon in March 
2008, in the International Journal of Drug Policy (Volume 
20/6). The guest editors (Henri Bergeron and Peter Reuter) 
suggest that after a period of relative stability in the 1990s, 
drug policy now appears to be in a state of fl ux, particularly 
in Europe. Whereas the ultimate goal of previous legislation 
and policy was to save users from themselves, there seems to 
be a shift towards policies that seek to protect communities, 
society and public order.
Increased controls on rave parties, legislation against 
drugs and driving, and the development of drug testing 
are examples; the authors note that such initiatives have 
been particularly prominent in Ireland, the Netherlands, 
Great Britain and Belgium. They note the same tendency in 
policies regarding alcohol consumption. While they observe 
that treatment and harm reduction policies still seek to 
minimise the adverse consequences of use for drug users 
and to care for drug users, greater attention is being given 
to public health concerns, as evidenced by the growing 
adoption of epidemiological and risk reasoning to analyse 
drug issues – a reasoning that reframes drug use in terms of 
epidemics that should be controlled as a threat to the public 
health of communities and society. 
The authors associate this increasing focus on negative 
consequences for communities and society, rather than on 
harm to the individual, with growing activism by civil society 
groups. Individuals tend now to group and call on the state 
to handle the collective negative consequences of drug use, 
such as the gathering of drug users in their neighbourhood, 
syringes in the streets and playgrounds, and dealing in the 
street. The authors suggest that a new actor – the ‘victim’, 
the one experiencing drug-use-related troubles, as opposed 
to the user – may be appearing in the drug policy arena and 
infl uencing policy decisions. www.ihra.net/www.issdp.org 
In June 2009 Crosscare’s Drug & Alcohol Programme 
(DAP) launched a website listing counsellors’ contact details. 
The purpose is to provide a national online database of fully-
qualifi ed and accredited counsellors/psychotherapists and 
professional counselling centres operating in Ireland. 
www.counsellingdirectory.ie 
On 10 July 2009 the Alcohol Marketing Communications 
Monitoring Body (AMCMB) published its third annual 
report. It concludes that there had been overall compliance 
in 2008 with the Voluntary Codes to limit the exposure of 
young people to alcohol advertising. www.dohc.ie 
On 2 September 2009 the National Offi ce for Suicide 
Prevention published its 2008 annual report. Among other 
matters, it reports on prevention activities that focus on 
substance awareness. www.dohc.ie
On 10 September 2009 the Mental Health Commission 
(MHC) published the Report of the Joint Working Group 
on mental health services and the police 2009. The authors 
state that a considerable proportion of social crises in the 
community are of a psychiatric nature, involving both 
adults and children, and are often connected not just with 
mental illness but with a range of other social factors, 
including alcohol and drug abuse. They recommend 
the urgent implementation of national policy in relation 
to the document Vision for Change and the Primary 
Care Strategy; the creation of a 24-hour, 7-day a week 
statutory social work service; expanding training for the 
Garda Síochána on community and social services; joint 
protocols between the mental health services and the Garda 
Síochána, and involving users and carers in the drawing up 
of these protocols; a feasibility study on jointly-staffed crisis 
intervention teams, made up of mental health personnel 
and members of the Garda Síochána; and court diversion 
programmes for dealing with minor criminal matters 
involving individuals with mental health problems. 
www.mhcirl.ie 
On 24 and 25 September 2009 the European Society for 
Social Drug Research (ESSD) held its 20th conference in 
Belfast. Conference themes included drug policy, trends and 
patterns in drug use, drug markets, drug-using lifestyles, 
theories and concepts, and methodological perspectives in 
drug research. www.essd-research.eu.
On 10 October 2009 the renewed Programme for 
Government was released. Alcohol and drugs are 
mentioned three times under the heading A More Caring 
and Just Society: ‘We will introduce stricter requirements for 
labelling of alcohol products … We will implement the new 
Drugs Strategy… We will continue to target Garda actions 
within communities experiencing signifi cant anti-social 
behaviour and drug crime.’ www.taoiseach.ie 
On 15 October 2009 a Community Cashback Fund of £4 
million was launched as a pilot scheme by the UK’s Home 
Offi ce. Using cash and assets seized from criminals, the fund 
gives local people a direct say in how criminal assets are 
spent. More than 45,000 votes were received from members 
of the public for 1,225 community projects via a dedicated 
website, and through neighbourhood policing meetings and 
citizens’ panels; 269 projects have been allocated funding 
for 2009/10. www.cashback.cjsonline.gov.uk/
On 28 October 2009 Issues to Consider before Reforming 
California State Law regarding Marijuana were presented 
by Rosalie Liccardo Pacula, Co-Director of the RAND Drug 
Policy Research Center (DPRC), before the California State 
Assembly Public Safety Committee. An economist, Pacula 
argues that California has insuffi cient information to decide 
on the matter and that it should conduct a full cost-benefi t 
analysis. She explores the challenges and identifi ed the 
important factors to consider in constructing a realistic cost-
benefi t calculation of the legalisation of marijuana. 
www.rand.org/multi/dprc 
In October 2009 the Joseph Rowntree Foundation 
published Communities in recession: the reality in 
four neighbourhoods. It describes the circumstances of 
disadvantaged people and communities in four areas in 
England and Wales during the recession, as observed in 
July 2009. Author Karen Day concludes, ‘… the current 
debate over the offi cial end of the recession is premature. 
All the political parties have acknowledged the inevitable 
future reduction in public services, fuelled by higher public 
borrowing and a decrease in tax receipts. But what hasn’t 
been recognised is the potential impact these cuts may 
have, triggering a second recession unique to deprived 
communities. Many of these places are dependent on public 
services – from free school buses to drug outreach services, 
even police community support offi cers – to cushion their 
community infrastructure. In the rush to proclaim the end of 
the economic downturn, these places could be overlooked 
just as these cuts start to bite, pulling them further into 
poverty and widening the gap in inequalities even more.’ 
www.jrf.org.uk 
(Compiled by Brigid Pike) 
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Recent publications
Journal articles
Management of neonatal abstinence syndrome: 
a national survey and review of practice
O’Grady MJ, Hopewell J and White MJ
Archives of Disease in Childhood. Fetal and Neonatal Edition 
2009; 94(4): F249–52 
www.drugsandalcohol.ie/12395/
Aim: To ascertain the present management of neonatal abstinence 
syndrome (NAS) in neonatal units in the UK and Ireland.
Methods: Postal questionnaire to 235 neonatal units, with 
telephone follow-up of non-respondents.
Results: The response rate was 90% (211/235), and 96% 
(190/211) of respondents had a formal NAS guideline. The 
median number of infants treated annually for NAS was 
six (range 1–100). The method of Finnegan was the most 
widely used scoring system (52%) for the UK and Ireland 
combined and 93% for Ireland. Morphine sulphate was the 
most commonly used fi rst line agent for both opiate (92%) 
and polysubstance (69%) withdrawal. Phenobarbitone was 
used as a fi rst line therapy in 62% of units based in Ireland. 
Dosing regimens varied widely. Units using a maximum daily 
morphine dose of <400 microg/kg/day were more likely 
to require the addition of a second agent (76% vs 58%, p 
= 0.027). Phenobarbitone was the drug of choice to treat 
seizures secondary to both opiate and polydrug withdrawal 
in 73% and 81% of units, respectively. Fifty-seven (29%) 
units allowed infants to be discharged home on medication; 
of these, 58% allowed administration of opiates in the 
community and in almost half of cases this was managed 
by a parent. Mothers on methadone whose serology was 
positive for hepatitis B and/or hepatitis C were four times 
more likely to be discouraged from breastfeeding. Over half 
(55%) of the units had a liaison midwife.
Conclusions: The majority of units currently use an opiate as 
the drug of fi rst choice as recommended. Doses utilised and 
second agents added vary signifi cantly between units. Many 
of our fi ndings refl ect the lack of high-quality randomised 
studies regarding management of NAS.
Alcohol and drug screening of occupational drivers for 
preventing injury
Cashman CM, Ruotsalainen JH, Greiner BA, Beirne PV and 
Verbeek JH
Cochrane Database of Systematic Reviews 2009, Issue 2. 
Art. No.: CD006566. DOI: 10.1002/14651858.CD006566.
pub2. www.drugsandalcohol.ie/11870/
The objective of this review was to assess the effectiveness 
of alcohol and drug screening of occupational drivers who 
operate motorised vehicles in preventing injury or work-
related effects such as sickness absence related to injury.
Studies included in this review were selected from among 
the following: randomised controlled trials (RCTs), cluster-
randomised trials, controlled clinical trials, controlled 
before and after studies (more than three time points to be 
measured before and after the study) and interrupted time-
series (ITS) studies that evaluated alcohol or drug screening 
interventions for occupational drivers (compared to another 
intervention or no intervention) with an outcome measured 
as a reduction in injury or a proxy measure thereof.
Two review authors independently extracted data and 
assessed study quality. Authors of the included studies 
were contacted for further information.
The review authors included two interrupted time-series 
studies conducted in the USA. One study was conducted 
in fi ve large US transportation companies (N = 115,019) 
that carried passengers and/or cargo. Monthly injury rates 
were available from 1983 to 1999. In the study company, 
two interventions of interest were evaluated: mandatory 
random drug testing and mandatory random and for-cause 
alcohol testing programmes. The third study focused only on 
mandatory random drug testing and was conducted on federal 
injury data that covered all truck drivers of interstate carriers.
Results were recalculated from raw data provided by the 
study authors. Following re-analysis, it was found that in one 
study mandatory random and for-cause alcohol testing was 
associated with a signifi cant decrease in the level of injuries 
immediately following the intervention (-1.25 injuries/100 
person years, 95% CI -2.29 to -0.21) but did not signifi cantly 
affect the existing long-term downward trend (-0.28 
injuries/100 person years/year, 95% CI -0.78 to 0.21).
Mandatory random drug testing was signifi cantly associated 
with an immediate change in injury level following the 
intervention (1.26 injuries/100 person years, 95% CI 0.36 
to 2.16) in one study, and in the second study there was 
no signifi cant effect (-1.36/injuries/100 person years, 95% 
CI -1.69 to 0.41). In the long term, random drug testing 
was associated with a signifi cant increase in the downward 
trend (-0.19 injuries/100 person years/year, 95% CI -0.30 to 
-0.07) in one study, the other study was also associated with 
a signifi cant improvement in the long-term downward trend 
(-0.83 fatal accidents/100 million vehicle miles/year, 95% CI 
-1.08 to -0.58).
The authors conclude that there is insuffi cient evidence to 
advise for or against the use of drug and alcohol testing of 
occupational drivers for preventing injuries as a sole, effective, 
long-term solution in the context of workplace culture, peer 
interaction and other local factors. Cluster-randomised trials 
are needed to better address the effects of interventions for 
injury prevention in this occupational setting.
An illustrative picture of Irish youth substance use
Van Hout, MC
Journal of Alcohol & Drug Education 2009; 53 (1): 7–14 
[Letter to the Editor] www.drugsandalcohol.ie/12266/
This letter describes recent exploratory research in Ireland 
undertaken to provide a snapshot of the perspectives of 
youth, community, addiction, educational and health 
service providers on youth substance use and current service 
provision. Interviews were undertaken with a self-selecting 
sample (based on availability, n=78) of these service 
providers in the South Eastern region of Ireland, which 
covers 13.5% of the State area and represents 20% of the 
national population. All interviews were analysed according 
to the themes that most consistently arose and that were 
pertinent to the research aims. The research yielded a picture 
of Irish youth substance use in terms of substances used, the 
potency of the peer and family setting for use and gaps and 
defi cits in targeted service response. 
Most interviewees felt that youth drug and alcohol use was 
increasing and of greater concern due to higher levels of 
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experimentation across all age groups and genders, with 
increased potential for the development of problematic 
use. Drug use was reported to present at ages 10 to 12 
years, with alcohol as the most common precursor to 
drug initiation. Some remarked that boys were likely to 
experiment at earlier life stages than girls; but other service 
providers commented that girls were now presenting with 
increased levels of experimentation. 
In general, it was reported that young people do not 
perceive their substance use to be of any risk to them, and 
that often the risk adds to the thrill of drug taking. It appears 
that negative fi rst-time experiences do not deter them from 
using again, and that drug decisions are stimulated and 
encouraged by the strength of the relationship with the peer 
group in learning new drug-taking behaviours, attaching 
meaning to the drug experiences, and providing the context 
for drug use. For patterns of use, it was observed by those 
working closely with young substance users that internal 
sanctions for use were present and served to control levels 
of drug taking and combining, certain ways to behave and 
levels of drug use. It appears that young substance users 
do not want to appear either addicted or out of control, 
and that youth substance use is increasingly a social activity 
and not a criminal one. In addition, there is a reported 
‘hierarchy’ of drugs in causing potential harm and social 
accommodation within youth culture, with heroin at the 
top of the scale and cannabis/hash at the lower end. Of 
some concern was the perception by some young people 
that heroin was safe if smoked and not administered 
intravenously. Most young people considered cannabis to be 
as safe as smoking cigarettes and were not concerned with 
any future health impact.
The research provides a key insight into the opinions, 
thoughts and knowledge relating to youth substance use 
from the viewpoints of a range of service providers. One 
must note that this information is based on ‘perceptions’ and 
is therefore anecdotal evidence. However, the information 
garnered in this study is useful in presenting the regional 
situation and guiding resources for timely drug and alcohol 
prevention strategies and community initiatives. In light of 
the fi ndings, it is recommended that a multi-disciplinary 
approach involving individuals, health services, parents, 
schools, and local communities offer the most success in 
dealing with youth substance use trends.
Learning and memory defi cits in ecstasy users and their 
neural correlates during a face-learning task
Roberts GM, Nestor L and Garavan H
Brain Research 2009; 1292: 71–81
Research has consistently shown that ecstasy users display 
impairments in learning and memory performance. In 
addition, working memory processing in ecstasy users 
has been shown to be associated with neural alterations 
in hippocampal and/or cortical regions as measured by 
functional magnetic resonance imaging (fMRI). 
Using functional imaging and a face-learning task, we 
investigated neural correlates of encoding and recalling 
face-name associations in 20 recreational drug users whose 
predominant drug use was ecstasy, and in 20 controls. To 
address the potential confounding effects of cannabis use 
by the ecstasy-using group, a second analysis included 
14 previously tested cannabis users (Nestor L et al. 2008; 
Neuroimage 40, 1328–1339). 
Ecstasy users performed signifi cantly worse in learning 
and memory compared to controls and cannabis users. A 
conjunction analysis of the encode and recall phases of the 
task revealed ecstasy-specifi c hyperactivity in bilateral frontal 
regions, left temporal, right parietal, bilateral temporal, and 
bilateral occipital brain regions. Ecstasy-specifi c hypoactivity 
was evident in the right dorsal anterior cingulated cortex 
(ACC) and left posterior cingulated cortex. 
In both ecstasy and cannabis groups, brain activation 
was decreased in the right medial frontal gyrus, left 
parahippocampal gyrus, left dorsal cingulate gyrus, and left 
caudate. These results elucidated ecstasy-related defi cits, 
only some of which might be attributed to cannabis 
use. These ecstasy-specifi c effects may be related to the 
vulnerability of isocortical and allocortical regions to the 
neurotoxic effects of ecstasy.
Alcohol use and the Traveller community in the 
west of Ireland
Van Hout MC
Drug and Alcohol Review 2010; 29(1): 59–63
www.drugsandalcohol.ie/12256/ 
Introduction and Aims: The Traveller community as ethnic 
minority is vulnerable to problematic alcohol use, because 
of social exclusion, discrimination, lack of awareness and 
diffi culties in engaging with addiction treatment protocols. 
Design and Methods: This research yielded an exploratory 
account of Travellers and alcohol use according to the 
perspectives of the Travellers and key service providers in 
the west of Ireland, within the context of a large-scale study 
on Travellers and substance use. The research consisted of 
12 peer-accompanied focus groups of Traveller men and 
women (n = 57) and 45 semi-structured interviews with a 
self-selecting sample of key service agencies. The research 
themes related to Traveller culture and alcohol use, sex 
differences, reasons for consuming alcohol, attitude to 
alcohol use, problematic alcohol use, levels of alcohol harm-
related knowledge, perceptions of alcohol-related risk and 
experiences of addiction services. A thematic analysis of the 
information garnered guided this comparative analysis. 
Results: The Traveller community, and in particular Traveller 
men, are presenting with increasingly problematic alcohol 
use, because of dissipation of their culture and their 
experiences of marginalisation, discrimination, depression, 
illiteracy and poverty. Diffi culties engaging with law 
enforcement, community health and addiction services 
compromise their efforts to deal with this problem and 
home detoxifi cation attempts are common. 
Discussion and Conclusions: Services must aim to take into 
consideration the cultural needs of Travellers and provide 
appropriate educational materials, peer education programs 
and fl exible treatment approaches for those Travellers 
experiencing problematic alcohol use.
(Compiled by Louise Farragher)
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Upcoming events 
(Compiled by Louise Farragher – lfarragher@hrb.ie)
February
4 February 2010
Right here, right now – The third DDN/Alliance national 
service user involvement conference
Venue: Holiday Inn, Birmingham city centre
Organised by/Contact: Ian Ralph (Tel: +44 (0)20 7463 
2081 or Faye Liddle (Tel: +44 (0)20 7463 2205) for further 
information or book online 
www.cjwellings.com/righthererightnow 
Information: Building on the success of ‘Nothing about us 
without us’ in 2007 and last year’s ‘Voices for choices’, this 
event will feature inspirational presentations from service 
users from all different backgrounds and throw open new 
challenges for better policy and practice.
This conference will enable those who use drug and alcohol 
services, alongside treatment providers, policymakers, DAAT 
co-ordinators, commissioners and drug and alcohol workers, 
to feed in their experiences of what’s working and what’s 
not – and to share ideas for brighter and better service 
user involvement. The event will once again showcase the 
country’s innovative service user groups, who are invited to 
be part of a vibrant exhibition, and the video booth will be 
open for vox pops and feedback for the special issue of Drink 
and Drugs News.
March
15–16 March 2010
Fourth Annual Conference of the International Society for 
the Study of Drug Policy
Venue: Santa Monica, USA 
Organised by/Contact: RAND Drug Policy Research Center 
and UCLA’s Integrated Substance Abuse Program 
www.rand.org/multi/dprc/issdp2010/index.html 
Information: The theme of the conference is ‘The future 
of drug policy: trends in policy, research to practice and 
practices that should be researched.’ The conference should 
be of interest to policy makers, practitioners and academics 
from a wide array of disciplines who are engaged in drug 
policy analyses pertaining to drug markets, the harms caused 
by both the supply of and demand for drugs, and the 
intended and unintended consequences of policy. 
Anticipated plenary speakers include:
Antonio Maria Costa, Executive Director, United Nations • 
Offi ce on Drugs and Crime
Tom McLellan, Deputy Director, US Offi ce of National • 
Drug Control Policy (confi rmed)
María Elena Medina-Mora, General Director, National • 
Institute of Psychiatry in Mexico, and former member of 
the International Narcotics Control Board (confi rmed)
Dr Zunyou Wu, Director, National Center for AIDS/• 
STD Control and Prevention, Chinese Center for Disease 
Control and Prevention (confi rmed).
Immediately after the conference, on 17th March, there will 
be an ISSDP workshop on sociological and anthropological 
contributions to drug policy studies, under the title ‘Drugs, 
culture and society’. On the afternoon of 17th March there 
will also be a workshop on Developments in longitudinal 
modeling of drug use and associated outcomes.
15–18 March 2010
KBS Thematic conference: Alcohol and violence – 
relationships, causality, and policy
Venue: Turning Point Alcohol and Drug Centre, Melbourne
Organised by/Contact: Kettil Bruun Society for Social and 
Epidemiological Research on Alcohol
www.kettilbruun.org/Violence_Melb.htm
Information: The role of alcohol in violence has been in 
the news in Australia and some other countries recently. 
Meanwhile, a number of different research traditions have 
expanded our knowledge about when and how there 
are links, the magnitude of the relationships, and the 
effectiveness of policy and program interventions to reduce 
alcohol-related violence.
In this context, a thematic meeting of the Kettil Bruun 
Society for Social and Epidemiological Research on Alcohol 
will be hosted by the AER Alcohol Policy Research Centre 
at Turning Point Alcohol and Drug Centre. The organising 
committee includes Peter d’Abbs, Kate Graham, Michael 
Livingston and Robin Room.
April
22–23 April 2010
15th National Conference – Working with Drug and 
Alcohol Users in Primary Care 
Venue: SECC, Glasgow
Organised by/Contact: Royal College of General 
Practitioners, Sex, Drugs and HIV Task Group
www.healthcare-events.co.uk/conf/booking 
php?action=home&id=404 
Information: This conference is the largest event in the UK 
for GPs, shared care workers, drug users, nurses and other 
primary care staff, specialists, commissioners and researchers 
interested in and involved with the management of drug 
and alcohol users in primary care.
The topics to be covered include:
Exploring the recovery debate and personalisation • 
of treatment
Redefi ning harm reduction• 
Linkages between substance use, deprivation, • 
and social exclusion
Hidden harm in primary care• 
Tackling hepatitis C – have we got it right?• 
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Speakers include:
Ethan Nadelmann, US Drug Policy Alliance• 
David Liddell, Director of Scottish Drugs Forum• 
Dr Mary Hepburn, Princess Royal Maternity Hospital • 
Dr David McCartney, Lothian and Edinburgh Abstinence • 
Programme (LEAP)
Dr Roy Robertson, Edinburgh GP and Reader at • 
Edinburgh University
25–29 April 2010
Harm Reduction 2010: IHRA 21st International Conference
Venue: BT Convention Centre, Liverpool.
Organised by/Contact: International Harm Reduction 
Association
www.ihra.net/Liverpool/Home 
Information: Harm Reduction: The Next Generation is the 
theme of this conference. There are now two and a half 
decades of harm reduction experience. A substantial body 
of evidence shows the feasibility and effectiveness of harm 
reduction in a wide variety of social and cultural settings.
But what is needed as we move through to the third decade 
of harm reduction? How adequate are the models of harm 
reduction that have been developed? Is the ‘comprehensive 
package’ of harm reduction for HIV sustainable in low and 
middle income countries?
This theme will be refl ected throughout the conference 
programme, and has been chosen to embody:
Young People – who are both directly and indirectly • 
affected by drug use around the world, and must 
be engaged in the global harm reduction and drug 
policy dialogue
New Populations – including regions such as • 
Africa and Latin America, which have often been 
overlooked by harm reduction advocates and policies
New Interventions – including the need to address • 
non-injecting use, and to move beyond a focus on 
opiates and develop effective responses for stimulant 
users and emerging drugs and trends
New Challenges – including the need to improve • 
global resourcing for harm reduction, and to improve 
quality as well as coverage around the world.
June
23–25 June 2010 
Drugs alcohol and criminal justice: ethics, effectiveness 
and economics of interventions
Venue: Friends House, 173–177 Euston Road, 
London NW1 2BJ
Organised by/Contact: Conference Consortium, 
conference@conferenceconsortium.org
www.connectionsproject.eu/conference2010
Information: The ‘Connections’ Project, launched in 
Autumn 2007, managed by The European Institute of Social 
Services (EISS) of the University of Kent and co-funded by 
the European Commission Public Health Programme focuses 
on the potential for partnerships within criminal justice 
systems of the EU Member States to develop joined-up 
responses to drugs and related-infections, particularly HIV/
AIDS and hepatitis.
The University of Kent is delighted to announce the Second 
European Conference of the Connections Project, organised 
by the Conference Consortium and supported by Drink and 
Drugs News and Napo. 
The conference takes place at a time of unprecedented 
competition for scarce resources everywhere. To be able 
to demonstrate ‘value for money’ is critical and nowhere is 
this more so than in drug and alcohol treatment. Following 
previous conferences where we have examined the various 
treatment models and interventions available, this event will 
seek to tease out how different modalities can be delivered 
and combined to construct a comprehensive treatment 
system, offering accessible and effective options to those 
requiring help, demonstrating value for money. 
The conference will look at a range of interventions and 
treatments, from harm reduction to drug free ‘recovery’. 
The premise is that no one treatment modality can deal 
effectively with the complex range of presented need. The 
task of the conference is to discuss and debate how best the 
different components can be combined most effectively. 
Within the context of criminal justice systems, some of the 
key issues for the conference will be: 
Access and equivalence – what right do service users • 
have, are they ‘a patient or a prisoner’?
Evidence and effectiveness – what really works and • 
how do we demonstrate this?
How can we reconcile different philosophies and • 
shape a system based on choice and plurality?
Who decides what is offered and when – how do • 
we ensure the ‘informed consent’ and is there a 
place for compulsion?
What role should and can service users play in service • 
design and delivery?
August
24–27 August 2010
11th EASA Biennial Conference: Crisis and imagination
Venue: National University of Ireland, Maynooth
Organised by/Contact: European Association of Social 
Anthropologists
www.easaonline.org/conferences/easa2010/index.htm 
Workshop 058: Alcohol, culture and motherhood
Exact date and venue: TBC
Workshop convenors: Tanya Cassidy (NUIM) tcassidy@
uwindsor.ca 
Anne Fox (Galahad SMS Ltd/UCL) 
Information: Alcohol and cultural associations have been 
studied for a number of years and linked to important topics 
such as identity and gender. Traditional anthropological 
studies have found a near cross-cultural universal that, in 
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HRB strategy and organisational change
In December the Health Research Board launched its 
strategic business plan for 2010 –2014. The strategy sets 
out a new approach to funding research and a realignment 
of the HRB's resources to concentrate on providing direct 
benefi ts for patients, for population health and for the
health system.
Until recently, the HRB comprised a number of units 
with responsibility for research funding and a number of 
units, such as the Alcohol and Drug Research Unit, with 
responsibility for maintaining national health information 
systems and using evidence derived from these systems and 
other discrete research projects to support decision making 
in services management and policy formation. Under the 
new strategy, the work of the HRB will be carried out in a 
new arrangement of units that will help to provide a more 
integrated approach to the task of translating research 
fi ndings into health benefi ts.
Work on the national health information systems, such as 
the NDTRS and the NDRDI, will continue as before. The 
HRB will remain as Ireland’s focal point for the European 
Monitoring Centre for Drugs and Drug Addiction, and the 
National Documentation Centre will continue its research 
dissemination and educational work. Contact details for 
all staff working on the information systems, in the NDC 
and on drug and alcohol research within the HRB will 
remain the same as before. Therefore, while there will no 
longer be a distinct drug an alcohol research unit in the 
HRB, we do not envisage that the transition to our new 
organisational structure will affect our working relationships 
or communication with our stakeholders in any way.
We want to take this opportunity to thank you for your 
support and your interest in our work over the years and to 
wish you a Happy New Year. We look forward to working 
with you in 2010.
nations where alcohol is consumed, males tend to imbibe 
at a higher rate, whereas women are more likely to abstain. 
Two key exceptions to this cross-cultural gender division 
occur in Greece and in modern Ireland. Ireland, perhaps 
more than any other nation, is linked to the imaginings of 
alcohol, and recent studies have shown that younger Irish 
females may consume more than their male counterparts, 
which has sparked notions of a new ‘crisis’, which is of 
course not new or unique to Irish commentators.
Signifi cantly, these younger women are of childbearing 
age, and the image of the female drunkard is inextricably 
associated with inept motherhood in the public imagination 
(an image dating back to Hogarth’s Gin Lane [175]).
In a Europe which is redefi ning notions of motherhood, 
it behoves us to take stock of such imaginings in Europe 
around the so-called historical and cultural ‘crisis’ of 
mothers who drink.
This workshop will investigate these complicated imaginings 
of ‘crisis’ and its implications not only for children, but 
also for their mothers, and for nation states as they react 
to globalised health concerns regarding alcohol. Critical 
ethnographic discussions of issues associated with the 
increasingly accepted demonisation of a maternal drinker 
are clearly linked to images of mothers in general, and 
perhaps to alcohol as a cultural object more specifi cally.
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